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Abstract 
Putative Glucosyltransferase 11 from Citrus paradisi:  
Cloning, Recombinant Expression in Yeast, and Substrate Screening 
by 
Bruce E. Williams 
 Plant secondary products, which include the flavonoids, have a variety of roles in plant 
systems. Their roles include UV protection, antifeedant activity, pollinator attraction, stress 
response, and many others. Flavonoids also have effects on human physiology. Glucosylation is 
an important modification of many flavonoids and other plant secondary products. In grapefruit, 
glucosylation is important in the synthesis of the bitter compound naringin. Glucosyltransferases 
catalyze glucosylation reactions. Putative plant secondary product glucosyltransferases may be 
identified by the loosely conserved “PSPG box” amino acid sequence, and eleven have been 
isolated to date in Citrus paradisi. With current knowledge, however, biochemical 
characterization is the only way to determine with certainty the function of these enzymes. The 
hypothesis tested here is that PGT11 is a plant secondary product glucosyltransferase. To 
investigate the hypothesis, recombinant PGT11 (rPGT11) was expressed in yeast using the 
pPICZ A vector, and the enzyme was screened for glucosylation activity with flavonoid 
substrates of the flavanone, flavone, flavonol, and isoflavone subclasses. No significant activity 
was detected with any of the substrates screened; however, the tests should be repeated for 
verification. Flavonoids of other subclasses, phenolic acids, and other phenolics could be tested 
as well. 
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1. Introduction 
1.1 – Flavonoids: some of their roles in plants and effects in humans 
 Flavonoids arise from the phenylpropanoid pathway and are derived from the amino acid 
phenylalanine and malonyl-CoA (Winkel-Shirley 2001). Chalcones are the earliest in flavonoid 
biosynthesis; flavanones, flavones, flavonols, and other flavonoids are derived from chalcones 
(Winkel-Shirley 2001, Figure 1).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The flavonoid biosynthetic pathway (adapted from Heller 
and Forkmann 1988, Wamucho 2012). CHI: chalcone isomerase.  
IFS: isoflavone synthase. FSI: flavone synthase.  
F3H: flavanone 3β hydroxylase. DFR: dihydroflavonol 4-reductase.  
FLS: flavonol synthase. ANS: anthocyanidin synthase.    
   Naringenin chalcone (Chalcone) 
   Naringenin (Flavanone)    Isoflavone 
   Flavone 
   Flavonol 
   Dihydroflavonol    Leucocyanidin 
   Anthocyanidin 
   CHI 
   FSI    IFS 
   F3H 
   DFR    FLS 
   ANS 
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 Flavonoids are broadly distributed phenolic compounds in higher plants, and over 6000 
have been identified (Harbourne 1994 and ref. therein, Veitch and Grayer 2008 and ref. therein). 
A given plant, however, contains a smaller subset of these compounds. For example, of nine 
flavonoid subclasses, the most abundant in grapefruit are the flavanones, flavones, and flavonols; 
other subclasses are fewer or absent (Berhow et al 1998, McIntosh and Mansell 1990, Owens 
and McIntosh 2011).  
 Flavonoids have numerous roles in plants. For example, flavonoids are important for 
pollination of flowers. Flavonol aglycones are important regulators of pollen germination (Mo et 
al 1992). Flavonoid pigments, such as glycosides of delphinidin and cyanidin, attract pollinators 
to flowers (Harbourne and Grayer 1993 and ref. therein). For example, Waser and Price (1983) 
found that the anthocyanin pigments in the petals of Delphinium nelsonii provide an important 
visual stimulus for bee and hummingbird pollinators; white flowers had a much longer handling 
time, possibly because pollinators have difficulty in locating nectar reserves without the 
contrasting pigments of wild-type Delphinium flowers.  
 Flavonoids also figure in other types of plant-insect interactions. For instance, the 
flavonol quercetin 3-O-glucoside in mulberry leaves stimulates biting in the silkworm Bombyx 
mori (Hamamura et al 1962). Other flavonoids of the flavonol, flavone, flavanone, 
dihydroflavonol, and dihydrochalcone subclasses are also known to act as feeding stimulants or 
inhibitors; some flavonoids may stimulate feeding in one insect while inhibiting it in another 
(Harbourne and Grayer 1993 and ref. therein).  
 There is evidence that select flavonoids protect plants and their photosynthetic 
components from UV-B radiation damage. One study (Ormrod et al 1995) showed that mutant 
Arabidopsis thaliana lacking flavonoids in epidermal tissue were very sensitive to UV-B 
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radiation. Stapleton and Walbot (1994) found that purple-leaved maize (with anthocyanin 
pigments) suffered less DNA damage than green-leaved maize. These studies are reviewed in 
Harbourne and Williams (2000). 
 Many properties of flavonoids make them useful or of interest to humans. In Citrus, 
flavonoids initially garnered interest because of their effect on the taste and color of fruit (Owens 
and McIntosh 2011 and ref. therein). Naringin and other compounds in grapefruit and grapefruit 
juice can interact with various anti-cancer, anti-infectives, anti-inflammatory agents, cholesterol 
medications, and other drugs (Bailey et al 2013). Much of this interaction is due to inhibition of 
cytochrome P450 3A4, which is necessary for metabolism of a broad range of compounds 
(Bailey et al 1998). Properties such as antifungal and antibacterial activity could make flavonoids 
useful to humans. Salas et al (2011) showed that the flavanones prunin, hesperetin, 
neohesperetin, naringin, and some synthetically-modified derivatives of these compounds 
inhibited the growth of the fungi Fusarium semitectum, Penicillium expansum, Aspergillus 
parasiticus, and Aspergillus flavus. Another study (Mori et al 1987) demonstrated that datiscetin 
and quercetagetin inhibited Gram-negative Proteus vulgaris, and 7,8-dihyrdroxyflavanone 
inhibited Gram-positive Staphylococcus aureus; robinetin, myricetin, (+)-dihydrobinetin, and  
(-)-epigallocatechin acted against both S. aureus and P. vulgaris. For more information on 
antimicrobial flavonoids see the review by Cushnie and Lamb (2005).  
 Flavonoids have cardiovascular effects. One study showed that, of seventeen flavonoid 
compounds tested, the flavones apigenin and luteolin produced the greatest relaxation of porcine 
arteries in vitro (Xu et al 2007). Dietary flavonoids may reduce rates of coronary heart disease 
mortality (Harbourne and Williams 2000 and ref. therein). Hertog et al (1993), for example, 
found that flavonoid intake in 805 elderly men was correlated with a decreased incidence of 
4 
 
heart attack and death from heart disease. Frankel et al (1993) showed that, in vitro, mixed 
phenolics extracted from red wine, which include flavonols and anthocyanins (glucosides of 
anthocyanidins), decreased the copper-catalyzed oxidation of human low-density lipoprotein 
(LDL) and may help prevent atherosclerosis in vivo. In a second in vitro study, the same group 
measured the antioxidant effects of individual phenolics and some phenolic mixtures from red 
wine and red grapes on human LDL; among the compounds with the highest inhibition of LDL 
oxidation were catechin, myricetin, epicatechin, and rutin (Teissedre et al 1996).     
 Additionally, select flavonoids have shown cytotoxic effects against several types of 
human cancers in vitro, such as leukemia (Makino and Fujimoto 1999). Two benzyl 
dihydroflavonols from Baeckea frutescens were active against leukemia, skin, renal, and colon 
cancer cell lines (Lee et al 1996). Silva et al (1995) found that the flavones 4’, 7”-di-O-
methylamentoflavone and 7”-O-methylrobustaflavone were active against cancers of several 
types, including those of the breast, lung, colon, skin and prostate. Coghlan (1998) showed that 
genistein, an isoflavone from soy inhibits growth and angiogenesis of cancer cells, while leaving 
normal cells unharmed.  For more information on anti-cancer effects of flavonoids, see the 
review by Harbourne and Williams (2000).  
  
 1.2 – Glucosyltransferases (GTs) 
 Glucosyltransferases (GTs) are enzymes that catalyze the transfer a glucose group from a 
donor substrate to an acceptor substrate. Attachment of glucose groups (glucosylation) can 
stabilize molecules, affect molecules’ water-solubility and transportability within the plant, and 
affect availability of molecules for other biochemical processes (Vogt and Jones 2000 and ref. 
therein). Across all species, thousands of putative GT sequences have been identified (Vaistij et 
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al 2009); however, only about forty plant secondary product glucosyltransferases have been 
biochemically characterized (McIntosh, personal communication). Plant glucosyltransferases 
share a 44-amino acid consensus sequence known as the PSPG box; this motif is known to 
contain the binding site for sugar donor substrates such as UDP-glucose (Vogt and Jones 2000, 
Offen et al 2006). While putative glucosyltransferases may be identified by the presence of this 
motif, function cannot be reliably predicted based on sequence alone. For example, two 
glucosyltransferases from Dorotheanthus bellidiformis with only 20% identity, UGT73A5 and 
UGT71F2, transfer glucose to the same acceptors (Osmani et al 2009 and ref. therein, Vogt 
2002, Vogt et al 1997, and Vogt et al 1999). Glucosyltransferases with high identity can act upon 
different sets of substrates (Osmani et al 2009 and ref. therin).      
 
1.3 – Studying plant GTs 
 Our lab uses the grapefruit (Citrus paradisi, cv. Duncan) as a model system for studying 
flavonoid GTs. Grapefruit is a suitable model, because it has a wide variety of flavonoids, most 
of which are glucosylated derivatives known as flavonoid glucosides (Owens and McIntosh 
2011). In addition, chalcone, flavanone, and flavonol GT activities of enzymes isolated from 
grapefruit leaf tissue have been reported (McIntosh et al 1990). An enzyme purified from 
grapefruit tissue by McIntosh et al (1990) glucosylates the 7-hydroxyl position of the flavanone 
naringenin to form prunin. Subsequent rhamnosylation of C-2 of the glucose of prunin forms the 
diglycoside naringin, which comprises between 40 and 70 percent of the dry weight of young 
fruit tissues (Jourdan et al 1985, McIntosh and Mansell 1990). The bitter taste of naringin and 
other neohesperidosides arises from the O-linkage of C-1 of rhamnose to C-2 of glucose; 
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rutinosides, in which rhamnose is bound to glucose in a 1 à 6 O-linkage, are tasteless (Owens 
and McIntosh 2011 and ref. therein, Figure 2). 
 
 
   
  
 
 
  
 
  
  
  
 
 Due to low concentrations of GTs in grapefruit tissue, purifying the enzymes directly 
from plant sources is problematic. Cloning grapefruit GTs into expression vectors to produce 
recombinant enzyme in Escherichia coli and Pichia pastoris has been useful in production of 
protein in amounts sufficient for study (e.g., Owens and McIntosh 2009, Mallampalli 2009, Lin 
2011, Wamucho 2012, and Hayford 2012). Cloning and biochemical characterization of 
recombinant putative GTs also allow for study of structure-function relationships.  
 Our lab has identified eleven putative glucosyltransferases (PGTs). These were identified 
as PGTs based on the presence of the PSPG box. Several of our PGTs have been expressed in E. 
coli to determine the activity of the recombinant proteins; however, E. coli often package the 
Naringenin 
(aglycone) 
Prunin 
(naringenin 7-O-glucoside) 
Narirutin (tasteless) 
 
Naringin (bitter) 
 
1 
2 
1 6 
Flavanone
7GT 
1-2 RT 
1-6 RT 
Figure 2. Biosynthesis of naringin and narirutin in Citrus (adapted from Owens and 
McIntosh 2011). Flavanone 7GT: flavanone 7-O-glucosyltransferase. 1-2 RT and 1-6 RT: 1-2 
rhamnosyltranferase (links C-1 of rhamnose to C-2 of glucose) and 1-6 rhamnosyltranferase (links 
C-1 of rhamnose to C-6 of glucose), respectively.  
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proteins into insoluble masses called inclusion bodies (e.g., Owens and McIntosh 2009, 
Mallampalli 2009, Ford et al 1998). When most of the protein of interest is in inclusion bodies, 
obtaining enough soluble protein to test for activity is difficult. In some cases, enough soluble 
protein is produced when culture conditions are optimized; however, alternate expression 
systems such as P. pastoris are needed to study some PGTs (Owens and McIntosh 2011).  
 Of eleven PGTs, PGT7 was shown to be a flavonol 3-O-glucosyltransferase (Owens and 
McIntosh 2009), and PGT 8 is 98% identical to a Citrus unshiu glucosyltransferase that 
glucosylates limonoids, a class of triterpenoids (Owens and McIntosh 2011 and ref. therein, 
Hayford 2012). Preliminary results for PGTs 3 and 9 show some activity with non-flavonoid 
phenolics (Wamucho 2012, Hayford 2012). Daniel et al (2011) showed that mRNA expression 
levels of these PGTs in Duncan grapefruit vary with tissue and maturity. 
 
1.4 – Previous work with PGT11 
 In previous work, Mallampalli (2009) mined the PGT11 contig from the harvEST 
bioinformatic database (see Figure 3 at the end of this chapter), PCR-amplified the sequence 
from young grapefruit leaf cDNA, and cloned it into the pCR®4-TOPO vector. Subsequently, 
Wamucho (2012) cloned PGT11 into the pPICZ A vector for expression in yeast. PGT11 from 
the harvEST database has over 80% identity and 90% similarity at the amino acid level to an 
uncharacterized and recently posted gene (orange1.1g012744m) in Citrus sinensis 
(www.phytozome.net).  
 Wamucho (2012) designed primers to amplify PGT11 from the pCR®4-TOPO vector 
with modified ends. Wamucho added to the 5’ end of PGT11 a KpnI restriction site and a yeast 
consensus sequence of the form (G/A)NNATGG, where ATG is the start codon. Such a sequence 
8 
 
can increase the efficiency of translation initiation in Pichia pastoris by 2 to 3 fold (Life 
Technologies 2011). The PGT11 sequence was such that the native start codon could not be used 
in the yeast consensus sequence, and it was necessary to add two amino acids at the N-terminal 
of the protein (Wamucho 2012). At the 3’ end of PGT11, a SacII restriction site was added and 
the native stop codon removed to facilitate recombinant expression with a C-terminal c-myc 
epitope (detection) and polyhistidine (purification) fusion tag (Wamucho 2012). 
 
1.5 – Hypothesis 
 In this work, recombinant PGT11 was expressed in the yeast Pichia pastoris (strain X-
33) using the pPICZ A expression vector. The hypothesis tested here was that PGT11 is a plant 
secondary product GT and, specifically, a flavonoid GT. The ultimate goal of this research was 
to fully characterize the function of PGT11. 
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ATGAGCAGTC CCCATGTTGT GGTAATACCG AATCCAGAAC AAGGGCATGT AATTCCTTTA 
CTAGAGTTGT CACAAAATTT GGCCAAGCAT GGCCTGAGAA TCACATTTGT GAACTCGGAG 
TATAATCACA ATCGGGTATT GGAATCATTA GAAGGAAAGA ATTACATTGG GGAGCAAATC 
CATCTGGTGT CGATCCCTGA TGGAATCGAA CCATGGGATG ACAGGAGTGA TATGAGAAAG 
TTGTTAGAAA AACGTTTACA GGTTATGCCT GGAAAGCTGG AGGGGCTCAT AGAAGAGATC 
CATGGAAGAG GAGGTGAAAA AATAGCTTGT CTCATTGCAG ATGGGGCAGC GGGGTGGGCT 
ATTGAAGTCG CTGAGAAGAT GAAACTCAGG CGGGCGGTTG TAGTGATAAC CTCAGCAGCA 
ACAGTGGCCT TGACATTCAG TATCCCTAAG CTGATAGAGG ATGGGGTCAT TAACAGTAAC 
GGGACTCCAA TCAAGGAACA AATGATTCAA TTGGCACCAA ATATGCCTGC AATAAGCACT 
GGAGAGCTAT TTTGGACTCG CTTTGGTGAC TTGACCATGC AAAAAATCTT CTTTGATTTT 
ATGGTGCAAA ACATGAGAGC GACGAGAGCG GTAGATTTCC AGTTATGCAA CTCAACATAC 
GAGCTGGAGG GTGGAGCATT CAGTATGATT CCGGAGCTTC TTCCAATAGG ACCACTTTTG 
GCGAGCAACC GGTTAGGAAA TTCAGCAGGA TACTTTTTGC CAGAAGACTC AAAATGTGTG 
GAATGGCTAG ACCAACAGCA AGCAAACTCA GTCATTTATG TTGCTCTGGG GAGCCACACG 
GTACTCGAGC AAAATCAGTT CCAAGAATTA GCATTAGGAC TTGAAATCTG CAACAGAGCG 
TTCTTATGGG TGGTGAGGCC AGATATTACC AATGATGCAA ATGATGCATA CCCTGAAGGA 
TTTCGAGAGA GAGTAGCCGC TCGAGGACAG ATGATCAGTT GGTCTCCTCA GCAGAAGTTT 
CTCACCCACC CTTCCATTTC CTGTTTCATG AGCCACTGCG GTTGGAATTC CACCACGGAA 
GGTGTGAGCA ACGGAGTCCC TTTCCTGTGT TGGCCATTCT TTGCTGACCA ATTCATGAAC 
ACCACCTACA TTTGTGATGT TTGGAAGGTG GGATTGAGGC TTGAAAGAAA CCAAAGTGGT 
ATTATCGGAA GAGAAGAAAT TAAGAACAAG GTGGATCAAG TGCTGGGTGA TCAAAATTTT 
AAGGCAAGGG CCTTAAAGCT TAAGGAAAAA GCCCTCAGTA GTGTCAGAGA AGGTGGTTCA 
TCCAACAAGG CAATTCAGAA TTTCGTTCAA TCCATCAAGC AATGGCCCGC ATGA 
 
 
MSSPHVVVIP NPEQGHVIPL LELSQNLAKH GLRITFVNSE YNHNRVLESL EGKNYIGEQI 
HLVSIPDGIE PWDDRSDMRK LLEKRLQVMP GKLEGLIEEI HGRGGEKIAC LIADGAAGWA 
IEVAEKMKLR RAVVVITSAA TVALTFSIPK LIEDGVINSN GTPIKEQMIQ LAPNMPAIST 
GELFWTRFGD LTMQKIFFDF MVQNMRATRA VDFQLCNSTY ELEGGAFSMI PELLPIGPLL 
ASNRLGNSAG YFLPEDSKCV EWLDQQQANS VIYVALGSHT VLEQNQFQEL ALGLEICNRA 
FLWVVRPDIT NDANDAYPEG FRERVAARGQ MISWSPQQKF LTHPSISCFM SHCGWNSTTE 
GVSNGVPFLC WPFFADQFMN TTYICDVWKV GLRLERNQSG IIGREEIKNK VDQVLGDQNF 
KARALKLKEK ALSSVREGGS SNKAIQNFVQ SIKQWPA 
 
 
A 
Figure 3. PGT11 contig sequence from the harvEST database (Mallampalli 2009).   
A: contig sequence (1374bp).  
 
B: amino acid translation of contig sequence (457aa). 
Color code (B only): Blue = positively charged side-group. Red = negatively charged side 
group. Gray = Polar but uncharged. Green = hydrophobic side group. Gold = hydrogen 
side group. Purple = proline, cyclic structure (can force bends).  
B 
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2. Experimental 
2.1 – Extraction of PGT11 D-pPICZ A Plasmid DNA from Escherichia coli by Midiprep 
 TOP10 E. coli (Invitrogen) containing PGT11 D-pPICZ A DNA (from Anye Wamucho’s 
colony D) (Wamucho 2012) were inoculated into 100 mL of Low Salt LBZeocin (25 mg/L) (Appendix 
A). The culture was grown for 16 hours in a New Brunswick I 24 incubator shaker at 37 °C, 250 
rpm. A culture of E. coli containing empty pPICZ A vector was prepared in the same manner. 
Plasmid DNA was extracted from two 50-mL aliquots of each culture using a Quantum Prep™ 
Plasmid Midiprep Kit (Bio-Rad). The midiprep was carried out according to manufacturer’s 
instructions; however, 30-second microcentrifugation steps were lengthened to 60 seconds to 
ensure that fluids were completely drained from the spin column.  
 The plasmid DNA was eluted in 600 μl of sterile dH2O; however, because a small (1.5-
mL) microfuge tube was used, not all of the 600 μL was eluted from the spin column on the first 
spin. Another 300 μL of dH2O was added to each spin column and the additional elution was 
collected in a fresh 1.5-mL microcentrifuge tube. The DNA concentration of each midiprep 
sample was measured using a Nanodrop-1000 spectrophotometer, its accompanying software 
(v3.5.2), and a 2-μL aliquot of each sample (Table 1 below).  
DNA Concentration (ng/μL) Total DNA in sample (μg) 
PA 1.I 57.1 30.0 
PA 1.II 30.2 11.3 
PA 2.I 53.8 29.9 
PA 2.II 26.2 9.0 
PG 1.I 115.4 60.6 
PG 1.II 51.1 19.2 
PG 2.I 131.9 66.0 
PG 2.II 52.0 20.8 
“PG” samples are PGT11 in pPICZ A vector. “PA” samples are empty pPICZ A vector. 
Samples with Roman numeral II are from second elutions from the spin columns. 
 Table 1. Concentrations of pPICZ A and PGT11-pPICZ A Plasmid DNA extracted from 
Wamucho’s (2012) E. coli colony D. 
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 To visualize the plasmid DNA, a 1-μL aliquot of the initial elutions and a 2-μL aliquot of 
the latter elutions were mixed with dH2O to a volume of 5 μL. The 5-μL samples were mixed 
with 1μL of blue/orange 6x loading dye (Promega) and were run for 45 min at 100 V on agarose 
(0.8 %) gel. The agarose gel was prepared in this manner: A 0.24-g portion of agarose powder 
(Fisher Scientific) was weighed into an Erlenmeyer flask. Then, TAE buffer (Appendix B) was 
added to a mass of 30g. The flask was then microwaved for 1 min 50 sec to dissolve the agarose 
in the TAE buffer. The flask was swirled smoothly to mix any remaining un-dissolved agarose 
and microwaved for an additional 30 seconds. After swirling again to mix and allowing the flask 
to cool for 1 minute, the flask was returned to the top-loading balance on which the agarose and 
TAE buffer had been weighed. To compensate for water evaporated during microwaving, dH2O 
was added until the mass of the agarose and TAE had returned to 30 g. The gel was stained 
before solidification by adding 2 μL of ethidium bromide (10 mg/mL) (prepared from ethidium 
bromide powder (Fisher Scientific)) which was swirled to mix. An additional 15 μL of ethidium 
bromide solution was added to the TAE running buffer and was mixed by stirring with a pipette 
tip.  
 
2.2 - Linearization of PGT11 D-pPICZ A plasmid   
 Before the PGT11-pPICZ A construct could be moved into yeast for expression of 
recombinant PGT11, it had to be linearized. The expression vector manufacturer’s manual (Life 
Technologies 2011) states that non-linearized plasmid may be transformed into P. pastoris; 
however, this requires 50 to 100 μg of plasmid DNA, whereas only 5 to 10 μg of linearized 
plasmid is required (Life Technologies 2011). The construct was linearized as recommended by 
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the pPICZ A vector manufacturer by cleavage at a single SacI restriction site within the AOX1 
promoter region.    
 Two digestions each were performed for pPICZ A and PGT11-pPICZ A plasmid DNA 
using samples PA 1.II, PA 2.II, PG 1.II, and PG 2.II from Table 1 above. Four microcentrifuge 
tubes were prepared as in Table 2 below, adding the restriction enzyme SacI (Promega) last. 
  
Tube 
Plasmid DNA 
(μL) 
10X Buffer J 
(μL) 
100X BSA  
(μL) 
SacI  
(μL) 
PA 1.II 375 42.6 4.26 4 
PA 2.II 345 39.2 3.92 4 
PG 1.II 375 42.6 4.26 4 
PG 2.II 400 45.4 4.54 4 
 
  
 
  
 The contents of each reaction were gently mixed by pipetting, then centrifuged for 20 
seconds in a tabletop centrifuge at 10 000 rpm. The digestions were incubated for 2 hours in a 
37°C water bath, after which 4 μL more SacI enzyme was added to each reaction. The samples 
were mixed and centrifuged as before and returned to the 37°C water bath for an additional two 
hours. To check the progress of the reactions, a 2-μL aliquot of each reaction mixture was run on 
an agarose (0.8%) gel as previously described. Three of the reactions appeared complete and 
were stopped by incubating them for 5 minutes at 65°C to denature SacI. The fourth reaction, 
PG2, was incomplete. An additional 4 μL of SacI (Promega) and 4.5 μL of 100X acylated BSA 
(Promega) was added to this sample, and it was mixed and centrifuged as before. The reaction 
was then returned to the 37°C water bath to incubate overnight (approximately 10 hours). The 
following morning, 4 μL more enzyme was added to the reaction, and the reaction was incubated 
for an additional four more hours after mixing and centrifuging as before. A 2-μL aliquot of the 
Table 2. SacI RE digestion reaction mixtures for linearization of PGT11 D-pPICZ A. The 100X BSA and 10X 
Buffer J solutions were purchased from Promega.  
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reaction was run as before on an agarose (0.8%) gel alongside 2-μL aliquots of the previously 
stopped reactions. The reaction was deemed complete. 
 
2.3 – Purification and concentration of linearized plasmid DNA 
         (phenol-chloroform extraction and ethanol precipitation) 
 To each digestion (linearization) reaction mixture was added an equal volume of phenol: 
chloroform: isoamyl alcohol (25:24:1) (Fisher Scientific). Each sample was then vortexed 
vigorously and microcentrifuged for 1 minute at 13 000 rpm. The top (aqueous) phase was drawn 
out of each tube and transferred to a fresh tube, and 1/10 volume of sterile (autoclaved) 3 M 
sodium acetate (granular sodium acetate from Fisher Scientfic) was added to each, followed by 
2.5 volumes of ice-cold 100% ethanol. The four samples were then vortexed for 3 to 5 seconds 
and incubated for 30 minutes in a -20°C freezer. 
 At the end of the incubation, the samples were microcentrifuged at 15 000 rpm, 4°C for 
15 minutes. The supernatant was carefully decanted and each DNA pellet was gently rinsed (not 
re-suspended) with 250 μL of ice-cold 80% ethanol to remove salts from the precipitate. The 
samples were then centrifuged at 15 000 rpm, 4°C for 10 min. The supernatant was carefully 
decanted, and the pellets were dried by inverting the tubes for 15 minutes at room temperature on 
a double layer of Kimwipes (Kimberly-Clark). Each pellet was re-suspended in 10 μL of sterile 
dH2O. A 1:20 dilution was made of each concentrated, linearized plasmid DNA solution, and 1- 
and 2-μL aliquots of each 1:20 dilution were run alongside 10 μL of exACTGene 1 kb plus DNA 
ladder on an agarose (0.8%) gel as described previously.  
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2.4 – Transformation of linearized PGT11 D–pPICZ A plasmid into Pichia pastoris 
 P. pastoris (X-33) was inoculated from glycerol stock into 5 mL of YPD medium 
(Appendix A) and incubated for approximately 24 hours in a New Brunswick I 22 Incubator 
Shaker at 30 °C, 250 rpm. A 100-μL portion of this culture was used to inoculate 100 mL of 
fresh YPD medium, and this larger culture was grown for approximately 15 hours at 30°C, 250 
rpm to A600 = 1.4. An A600 in the range of 1.3 to 1.5 indicates that the yeast are in the proper 
growth phase to be used for electroporation.   
 The yeast cells were harvested by centrifuging the 100-mL culture at 1500 x g for 5 min 
at 4°C. The supernatant was poured off and the pellet was re-suspended in 250 mL of ice-cold 
sterile dH2O to wash away the YPD media. The cells were then centrifuged as previously 
described and the supernatant was again discarded. Next, the cells were washed again by 
resuspending them in 150 mL of sterile dH2O. The cells were centrifuged again as previously 
described, the supernatant discarded, and the pellet re-suspended in 10 mL of sterile, ice-cold  
1 M sorbitol. The cells were centrifuged a final time, the supernatant discarded and the cells re-
suspended in 700 μL of sterile, ice-cold 1 M sorbitol for a final volume of approximately 1 mL. 
(Note: The yeast should have been re-suspended in a smaller volume of 1 M sorbitol. The Pichia 
Easy Select user’s manual (Life Technologies 2011) suggests that yeast from a 500-mL culture 
be re-suspended in 1 mL of 1M sorbitol. Thus, the procedure was not properly scaled down.) The 
1 M sorbitol maintains an isotonic environment for the yeast cells during the electroporation 
procedure and prevents them from lysing. This suspension of yeast in 1M sorbitol was 
transferred to a sterile 1.5-mL microcentrifuge tube and kept on ice until the electroporation 
approximately 2 hours later.  
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 An 80-μL portion of the yeast suspension was mixed with 9 μL of linearized, 
concentrated PGT11 D-pPICZ A DNA, and the mixture was transferred to an electroporation 
cuvette on ice. (Note: The concentrataion of the linearized plasmid was determined to be greater 
than 0.86 μg/μL by electrophoresis of 1 μl of a 1:20 dilution alongside quantitative standards; 
however, the exact concentration was not determined. See results section Figure 3 for image of 
agarose gel.) The cuvette was incubated on ice an additional five minutes, after which it was 
pulsed at 1.50 kV on manual setting in a Bio-Rad MicroPulser™ electroporation device. 
Immediately after pulsing, 1mL of ice-cold, sterile 1 M sorbitol was added to the cuvette. Next, 
the entire content of the cuvette was transferred to a sterile, 15-mL glass tube and incubated at 
30°C for 90 min without shaking. Following the incubation, 50 μL of cells were plated on 
YPDSZeocin (100mg/L) (Appendix A). On another plate, 100 μL of cells were plated. The remaining 
cells were stored at 4°C. 
 The plates were incubated at 28°C. After three days, a single colony was visible and was 
designated colony A. The plate with colony A was stored at 4°C, and the remaining 
electroporation mixture was spread over five more fresh YPDSZeocin (100mg/L) plates which were 
also incubated at 30°C. Three days later, five more colonies had grown on the plates and were 
designated B, C, D, E, and F. Colonies were screened by PCR to confirm that they contained the 
insert for PGT11. 
 
2.5 – PCR screening of P. pastoris to confirm presence of PGT11 insert 
 A small bit of each colony A through E was scraped from the YPDS plates with a sterile 
pipette tip and re-suspended in 10μL of dH2O in a 200-μL tube. The remainder of each colony 
was scraped from the plates with an inoculation loop and inoculated in 5 mL of YPD which was 
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incubated for 18 hours at 30°C, 250 rpm. (Note: The colonies were not re-streaked on fresh 
plates as they should have been in order to confirm antibiotic selection and ensure the selection 
of a single colony.) The cells re-suspended in water were lysed according to the protocol given 
by Life Technologies (2011). A 5-μL portion of lyticase (5 U/μL) (lyophilized lyticase powder 
from Sigma-Aldrich, SKU 2524) was added to each sample, and the samples were incubated at 
30°C for 10 minutes. After incubation, the samples were frozen at -80°C for 10 minutes.  
 A 1-μL aliquot of cell lysate from each of the six colonies was added to six, 200-μL PCR 
tubes. To serve as a positive control, 1μL of PGT11-pPICZ A midiprep DNA isolated from E. 
coli (section 2.1) was added to a seventh PCR tube. To serve as a negative control, 1μL of empty 
pPICZ A vector midiprep DNA from E. coli was added to an eighth PCR tube.  The following 
PCR master mix was prepared: 45.2 μL dH2O, 16 μL 5X Green GoTaq™ DNA polymerase 
reaction buffer (Promega), 4 μL of 10μM AOX1 5’ primer, 4 μL of 10μM AOX1 3’ primer, 
0.8μL of 10mM dNTPs mix (Promega), and 2 μL of GoTaq™ DNA polymerase. Then, 9 μL of 
the master mix was added to each of the eight PCR tubes. (Note: Promega recommends only 
0.25 μL of GoTaq DNA polymerase per 50-μL reaction, whereas 0.25 μL per 10-μL reaction was 
mistakenly used here. Promega recommends that 2 mM of each dNTP, whereas 1 mM of each 
dNTP was used here; for screening of P. pastoris transformed with pPICZ A constructs, Life 
Technologies (2011) recommends 0.5 mM in each dNTP. Concentration of each primer was 
0.5μM and falls within Promega’s suggested range of 0.1 to 1.0μM.)   
 See Tables 3 and 4 below for the details of PCR cycling and primer information. (All 
primers were purchased from Integrated DNA Technologies.) After cycling, the 10-μL reactions 
were run on agarose (0.8%) gel as previously described. Glycerol stocks of the positive colonies 
were prepared from the overnight cultures by adding 500 μL of sterile 50% glycerol (glycerol 
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from Fisher Scientific) to 500μL of culture. The stocks were mixed by vortexing for 5 seconds 
and then stored at -80°C.  
  
Step Temperature (°C) Time (s) No. of cycles 
Initiation 94 120 1 
Denaturation 94 30 
30 Annealing 51 30 
Elongation 72 90 
Final Elongation 72 300 1 
 
  
Primer Sequence Tm (°C) 
5’ AOX1 5’ – GACTGGTTCCAATTGACAAGC – 3’ 54.3 
3’ AOX1 5’ – GCAAATGGCATTCTGACATCC – 3’ 54.8 
 
 
 
2.6 – Test inductions of recombinant PGT11 
 Pichia pastoris have the ability to use methanol as their sole carbon source in the absence 
of carbohydrates; this is accomplished by the oxidation of methanol to formaldehyde by the 
enzyme alcohol oxidase (Life Technologies 2011). Because alcohol oxidase has low binding 
affinity for molecular oxygen, Pichia compensate by up-regulating production of the enzyme via 
the AOX1 promoter, which is activated in the presence of methanol and the absence of 
carbohydrates (Life Technologies 2011). The gene of interest is cloned into the pPICZ A vector 
at the AOX1 promoter, thus expression of recombinant protein is also up-regulated by treatment 
with methanol (Life Technologies 2011).  
 Inductions were carried out as recommended in Life Technologies (2011), Wamucho 
(2012), and Hayford (2012), although the culture was scaled down to a smaller volume. Glycerol 
Table 3. PCR reaction conditions for confirmation of PGT11 D insert in transformant P. pastoris colonies. 
Table 4. Primers used for PCR screening of PGT11 D-pPICZ A transformants. 
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stock of transformant yeast colony F was inoculated in 5 mL of YPD medium (Appendix A) and 
incubated for approximately 18 hours at 30°C, 250 rpm. A 100-μL aliquot of the overnight 
culture was used to inoculate 50 mL of BMGY (Appendix A) medium in a 250-mL flask. These 
first two cultures were grown to generate the mass of cells required before induction with 
methanol. 
 The second overnight culture was grown approximately 18 hours to A600 = 2.0 and was 
harvested by centrifugation at room temperature at 3000 x g for 5 minutes. The pellet was re-
suspended in 100 mL of BMMY medium (Appendix A) to remove any remaining carbohydrate 
from the BMGY or YPD medium. The cells were then centrifuged as before, the supernatant 
discarded, and the pellet re-suspended in 200mL of BMMY to an A600 = 1.2. 
 Two 1-mL samples representative of pre-induction conditions were taken immediately 
after re-suspension in the BMMY. The samples were spun in a microcentrifuge for 3 min at  
13 000 rpm, and the supernatant was discarded. The pellets were stored at -80°C for later 
analysis. Of the remaining culture, 25 mL was poured into a sterile, 250-mL flask which was 
incubated at 30°C, 250 rpm for 4 days. Two 1-mL samples were taken at 6, 12, 18, 24, 36, 48, 
72, and 96 hours post-induction and processed in the same manner as the pre-induction samples. 
In the second and third trials, with colonies A and B, the 96 hour sample collection was omitted. 
In order to maintain induction conditions throughout the four-day period, 100% methanol was 
added every 24 hours to a final concentration of 0.5%. 
 
2.7 – Extraction of protein from PGT11 D-pPICZ A pre- and post-induction samples 
 Pre- and post-induction cell pellets were thawed on ice. Approximately 100 μL of acid-
washed glass beads (bead diameter = 0.5 mm) (Sigma) were added to each pellet. In the first 
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attempt to detect recombinant enzyme (using colony F), 1 mL of breaking buffer (Appendix B) 
was mistakenly added to each pellet; in subsequent trials (using colonies A and B), 100 μL of 
breaking buffer was added to each pellet. 
 The cells were lysed by vortexing the samples for 30 seconds at maximum speed and 
then cooling them on ice for 30 seconds. Vortexing and cooling steps were repeated for a total of 
eight cycles. The lysed cells were then microcentrifuged at 14 000 rpm, 4°C for 10 min. The 
supernatant was transferred to a fresh 1.5-mL microfuge tube, and the protein concentration of a 
2-μL aliquot of each sample was read on a Nanodrop-1000 spectrophotometer in “Protein A280” 
mode, which reads an A280 = 1 as a concentration of 1 mg/mL.   
 
2.8 – SDS-PAGE and staining of protein gels 
 Attempts were made to detect recombinant PGT11 using three transformant colonies. In 
the first attempt to detect recombinant protein, protein samples were more dilute, and 9.9 μg of 
each crude protein was analyzed by SDS-PAGE and Western blot. In the latter two trials, less 
breaking buffer was used to extract protein, and samples were more concentrated. Thus, a 50-μg 
portion of crude protein from each sample was analyzed. Samples were prepared for SDS-PAGE 
by adding the appropriate amount of protein, diluting with dH2O to a volume of 18 μL, then 
boiling for 5 minutes with 6 μL of 4X SDS-PAGE Sample Buffer. (Recipes of all stocks, 
solutions, and buffers used for SDS-PAGE and Western blot are in Appendix B.)  
 Protein samples were loaded into a 0.75-mm gel with a 5% acrylamide (pH 6.8) stacking 
gel and a 10% acrylamide (pH 8.8) separating gel. The separating gel was prepared by mixing 
1.3 mL of 40% acrylamide/bisacrylamide mix (Bio-Rad), 2.3 mL dH2O, 1.3 mL 4X separating 
buffer, 50 μL 10% SDS, 2 μL TEMED (Fisher Scientific), and 50 μL of 10% APS (freshly 
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prepared from ammonium persulfate powder from Fisher Scientific). APS and TEMED were 
added last, and the gel was poured to a level of 2 cm from the top of the gel cassette (Bio-Rad 
MiniProtean, 0.75 mm), being careful not to introduce bubbles into the gel. The separating gel 
was overlaid with approximately 400 μL of water-saturated n-butanol and allowed 20 minutes to 
solidify. The n-butanol overlay was poured off, and residual n-butanol and any non-polymerized 
acrylamide was blotted away with filter paper and/or rinsed away with dH2O. The stacking gel 
was prepared by mixing 260 μL of 40% acrylamide/bisacrylamide mix (Bio-Rad), 1.5 mL dH2O, 
250 μL 4X stacking buffer, 20 μL 10% SDS, 2 μL TEMED, and 20 μL of 10% APS. APS and 
TEMED were added last, and the stacking gel was poured until its level reached the top of the 
gel cassette. Immediately, a comb was inserted into the top of the cassette to form fifteen wells, 
and the gel was given 20 min to solidify. Electrophoresis was done in 1X Tris-glycine 
electrophoresis buffer (Appendix B).     
 The electrophoresis was run at 80 V for about 15 min until the dye front reached the 
separating gel, then the volatage was increased to 100 V (Devaiah, personal communication) and 
the gel was run for approximately 90 more minutes until the dye front reached the end of the gel. 
In the first attempt to detect recombinant PGT11, duplicate gels were run. The first was stained 
in Coomassie blue, while the second was used for a Western blot. Due to low protein 
concentrations in the first trial, bands detected with Coomassie blue were very faint. Therefore, 
the gel was destained in destaining solution (50:40:10 :: dH2O : methanol : glacial acetic acid) 
(methanol and acetic acid from Fisher Scientific) and silver stained with a Silver Stain Plus Kit 
(Bio-Rad) according to manufacturer’s directions. In the second and third trials, a single gel was 
run and analyzed by Western Blot. Duplicate gels were not run because gels for Western blot 
were run first, and, after the Western blots failed to detect expression of recombinant PGT11, a 
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frameshift was discovered between the insert and the fusion tag used for detection. Thus, any 
further work to detect expression of recombinant protein in these cells lines was abandoned.  
 
2.9 – Western blot analysis for detection of recombinant enzyme 
 The SDS-PAGE gel was electroblotted in transfer buffer (Appendix B) onto a 
nitrocellulose membrane (Thermo Scientific) at 65 V for 1 hour. The membrane was then placed 
in blocking solution (5% non-fat milk powder in 1X TBS with 0.02% sodium azide) (non-fat 
milk powder from TOPCO Associates, LLC.; sodium azide from Fisher Scientific) for 2 hours at 
room temperature with gentle agitation. After blocking, the membrane was incubated in primary 
antibody (a 1:2500 dilution of monoclonal mouse anti-c-myc (Sigma-Aldrich) in TBS with 
0.02% sodium azide) for 2 hours. This primary antibody binds the c-myc epitope which should 
be in the engineered fusion tag of recombinant PGT11. Next, the membrane was washed three 
times for 5 min each in 25 mL of TBS without azide. The membrane was then incubated in 
secondary antibody (a 1:10 000 dilution of goat anti-mouse IgG-AP (immunoglobin G-alkaline 
phospatase conjugate) (Novagen) in TBS without azide) for 2 hours with gentle agitation and 
washed three times with TBS as before. Next, the membrane was transferred to 15 mL of 
alkaline phosphatase buffer (Appendix B). The alkaline phosphatase substrates NBT and BCIP 
were added just before use. Because bands were not detected, the membranes were allowed to 
develop for 20 min until background protein bands appeared. The alkaline phosphatase reactions 
were stopped by placing the membrane in a mixture of 200 μL 0.5M EDTA, pH = 8.0 and 50 mL 
TBS (final concentration of 2 mM EDTA).   
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2.10 – Miniprep extraction of PGT11-pPICZ A and PGT11-TOPO DNA for sequencing 
 Because three attempts to detect recombinant protein by Western Blot were unsuccessful, 
the plasmid used to transform P. pastoris was sent for sequencing at the University of Tennessee 
Knoxville’s Molecular Biology Resource Facility to check for cloning errors. To obtain plasmid 
for sequencing, glycerol stock of two of Anye Wamucho’s colonies, A and D, containing 
PGT11-pPICZ A plasmid in E. coli were inoculated into tubes containing 5 mL of Low Salt 
LBZeocin (25mg/L) (Appendix A). Recall that DNA from PGT11-pPICZ A colony D was used to 
transform P. pastoris.  
 In addition, three of Anye Wamucho’s E. coli colonies, PGT11-TOPO 1, 2, and 3, 
containing PGT11 in the cloning vector pCR
®
4-TOPO, were each inoculated in 5 mL of 
LBAmpicillin (100mg/L) (Appendix A). To avoid ambiguity among sample names, Wamucho’s E. coli 
colonies PGT11-TOPO 1, 2, and 3 were re-named PGT11 AN-1–, AN-2–, and AN-3–TOPO, 
respectively. The cultures were grown overnight at 37°C, 250 rpm. Duplicate cultures were 
prepared, and one DNA sample of each pair was sent for sequencing at the University of 
Tennessee’s Molecular Biology Resource Facility. Plasmid DNA was extracted from the cultures 
with a Qiaprep Plasmid Miniprep Kit (Qiagen) according to manufacturer’s directions. The 
optional step of washing the spin column with 500 μL of PB (binding) buffer was included, and 
the DNA was eluted in 50 μL of sterile dH2O. 
 PGT11-pPICZ A DNA from Anye Wamucho’s E. coli colonies A and D (Wamucho 
2012) was sequenced with the following primers: 3’ AOX1, 5’ AOX1, CSP152F, and CSP153R. 
(Recall that DNA from colony D had been transformed into yeast.) PGT11-TOPO AN-1, AN-2, 
and AN-3 were sequenced with the following primers: T3, T7, CSP152F, and CSP153R. Priming 
sites for CSP152F and 153R are within the PGT11 sequence. Information for 5’ and 3’ AOX1 
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primers, which are complementary to the pPICZ A vector, was given previously in Table 4. T3 
and T7 primers are complementary to the PCR4®-TOPO vector. See additional information for 
the sequencing primers in Table 5 below.  
 Primer Sequence Tm (°C) 
CSP152F 5’ – TCT TTG ATT TTA TGG TGC AAA ACA TG – 3’ 53.3 
CSP153R 5’ – TTT TGA GTC TTC TGG CAA AAA GTA T – 3’ 53.3 
T3 5’ – ATT AAC CCT CAC TAA AGG GA – 3’ 50.3 
T7 5’ – TAA TAC GAC TCA CTA TAG GG – 3’ 47.5 
 
 
 
 Sequencing results revealed that each of the colonies PGT11-TOPO AN-1, AN-2, and 
AN-3 contained a slightly different variant of the PGT11 sequence (see Results). Clone AN-2 
was selected for further work. Wamucho’s PGT11-pPICZ A colony D contained clone AN-1 in 
the pPICZ A vector. In addition, a frameshift due to an extra base between the 3’ end of PGT11 
D insert and the fusion tag used for detection and purification was discovered.  
 
2.11 – PCR modification to correct 3’ frameshift 
 To correct the frameshift in the PGT11 insert, attempts were made to insert bases. 
Inititally, an attempt was made to insert two bases with the primers described below (Table 6). 
Primer Sequence 
Predicted 
Tm (°C) 
3’ CSP154R: 5'- CCT CCG CGG CCT GCG GGC CAT TGC TTG -3' 72.8 
5’ CSP138F: 5'- CGG GGT ACC GCC ATG GCC ATG AGC AGT CCC CAT G -3' 72.4 
 
  
 A 1-μL aliquot of PGT11 AN-2–TOPO miniprep DNA described in section 2.10 was 
used as template for the following PCR reaction, designated BW: 10 μL 5x colorless GoTaq 
Table 6. Mutagenic 3’ primer and non-mutagenic 5’ primer used in initial attempt to insert two 
bases to correct frameshift. CSP154R was designed to insert two bases. Underlined bases are 
complementary to desired insertion. 
Table 5. Primers used to sequence plasmid DNA after unsuccessful detection of expression of 
recombinant PGT11. Information for 5’ and 3’ AOX1 primers is given in Table 4, section 2.5. A 5 μM 
solution of CSP primers was prepared and sent with plasmid samples. All other primers were provided 
by the sequencing facility. 
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Buffer (Promega), 1 μL 10mM dNTPs (Promega), 5 μL 10μM CSP138F primer, 5 μL 10μM 
CSP154R primer, 27.5 μL sterile dH2O, 1 μL template DNA and 0.5 μL GoTaq DNA 
polymerase (5 U/μL) (Promega). (Note: Promega recommends 0.25 μL GoTaq per 50-μL 
reaction; however, more was used because it is difficult to pipette this small of a volume. 
Promega recommends 2mM of each dNTP; however, 0.2 mM was used here.) PCR conditions 
are given in Table 7 below. 
Step Temperature (°C) Time (s) No. of cycles 
Initiation 94 120 1 
Denaturation 94 30 
30 Annealing 50 30 
Elongation 72 90 
Final Elongation 72 300 1 
 
  
2.12 – TA vector cloning of BW PCR product and transformation into TOP10 E. coli  
 The TOPO TA Cloning Kit for Sequencing (Invitrogen) was used to clone the PCR 
product BW into the pCR
®
4-TOPO cloning vector. A cloning reaction was prepared according to 
manufacturer’s directions: 4 μL of the PCR reaction was mixed with 1 μL of supplied salt 
solution and 1 μL of TOPO vector. The cloning reaction was incubated at room temperature for 
30 min.  
 Two vials of chemically competent One-Shot TOP10 E. coli were thawed on ice. A 3-μL 
aliquot of the cloning reaction was added to a vial of competent cells and gently mixed with the 
pipette tip without pipetting up and down. As a positive control, 1 pg of pUC19 DNA was added 
to the second vial of competent cells. The cells mixed with transforming DNA were incubated on 
ice for 30 minutes after which they were placed in a 42°C water bath for 30 seconds and then 
immediately placed on ice for 150 seconds. The vials were then removed from the ice, and  
Table 7. PCR conditions for initial attempt to insert two bases to correct frameshift.  
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250 μL of Low Salt LB medium (Appendix A) was added to each. The vials were shaken 
horizontally in an incubator-shaker at 37 °C, 225 rpm for 75 min and 75- and 150-μL aliquots 
were spread over Low Salt LBAmp (100 mg/L) plates. After 15 hours of growth at 37°C, eight single 
colonies were selected from the plate and suspended in 100 μL of water.  
 A 1-μL aliquot of each cell suspension was used as template for PCR reactions to confirm 
the presence of PGT11 in the pCR4 TOPO vector. The following master mix was prepared:  
59 μL sterile dH2O, 24 μL 5x Green GoTaq reaction buffer, 2.16 μL 10mM dNTPs, 12 μL  
10 μM T3 primer, 12 μL 10μM T7 primer, and 1μL of GoTaq DNA polymerase (5U/μL). [Note: 
dNTPs were 0.2 mM each, whereas Promega recommends 2mM. Because of pipetting 
limitations, 1 μL of GoTaq was used for 120μL of reaction (0.083μL per 10-μL reaction), 
whereas Promega recommends 0.6 μL for the same volume (0.05 μL per 10-μL reaction).]  T3 
and T7 primers were previously described (Table 5). A 9-μL aliquot of the mix was added to  
1 μL of each template and the reactions were cycled as in Table 8 below. After PCR, the 
reactions were run alongside 5 μL of exACTGene 1kb plus DNA ladder on agarose 0.8% gel as 
described previously. 
  Step Temperature (°C) Time (s) No. of cycles 
Initiation 94 120 1 
Denaturation 94 30 
30 Annealing 50 30 
Elongation 72 120 
Final Elongation 72 300 1 
 
 
 
 
 
Table 8. PCR conditions for screening of PGT11 BW-TOPO transformants. 
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2.13 – Restriction of AN-2 insert from PGT11-TOPO BW-1 plasmid and restriction of  
            pPICZ A vector 
 One of the eight positive colonies containing the PGT11 AN-2—TOPO plasmid, BW-1, 
was selected for further work. It was re-streaked on a fresh Low Salt LBAmp (100mg/L) plate and 
incubated at 37°C for 16 hours. A single colony from this plate was inoculated into 5 mL of Low 
Salt LBAmp (100mg/L). In addition, E. coli containing empty pPICZ A vector were inoculated from 
glycerol stock into 5 mL of Low Salt LBZeocin (25mg/L). These cultures were incubated for 16 hours 
at 37°C, 250 rpm.  Plasmid DNA was extracted by miniprep as described previously. The 
concentration of each sample was measured as before using a Nanodrop-1000 
spectrophotometer. The concentration of BW-1 plasmid read over 600 ng/μL, so the 
concentration of a 1:20 dilution was read instead: 36.6 ng/μL. The concentration of pPICZ A 
plasmid was 175.6 ng/μL. Restriction digestions of the concentrated BW-1 plasmid (732 ng/μL) 
and pPICZ A plasmid were set up as in Table 9 below. 
Reaction 
Plasmid  
(μL) 
Plasmid  
(μg) 
10X buffer A 
(μL)  
10X BSA 
(μL) 
dH2O 
(μL) 
KpnI 
(μL) 
SacII  
(μL) 
KpnI 
1.37 of 1:10 
dilution 
0.10 1.00 1.00 5.6 1.00 --- 
SacII 
1.37 of 1:10 
dilution 
0.10 1.00 1.00 5.6 --- 1.00 
KpnI 
+ 
SacII 
1.37 1.00 2.00 2.00 12.6 1.00 1.00 
pPICZ A 5.69 1.00 2.00 2.00 8.3 1.00 1.00 
: 
   
  The reactions were incubated for 2 hours at 37°C after which they were run on agarose 
(0.8%) gel as described previously alongside 100 ng of each undigested plasmid. The bands 
corresponding to PGT11 insert and digested pPICZ A vector were excised from the gel and 
Table 9. Restriction digestions of BW-1 PGT11-TOPO and pPICZ A plasmid for ligation. 
Buffer A and restrictases were obtained from Promega. 10X BSA was prepared from 100X stock 
(Promega). 
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placed in pre-weighed 1.5-mL microfuge tubes. The DNA was then purified using a Wizard SV 
Gel and PCR Clean-up Kit (Promega) according to manufacturer’s directions with one 
modification: The DNA was eluted in 30 μL of sterile dH2O rather than 50 μL to increase the 
concentration of the samples; according to the kit manufacturer’s manual, elution volume may be 
reduced to as little as 15 μL without significantly decreasing yield (Promega 2010).  DNA 
concentration was measured as previously described using 2-μL aliquots of each sample (Table 
10 below).  
DNA Concentration (ng/μL) 
 PGT11 insert 8.8 
pPICZ A vector 16.2 
     
   
2.14 – Ligation of PGT11 AN-2 insert into pPICZ A vector and   
 transformation into TOP10 E. coli 
 The following ligation reaction (moles of vector:moles of insert = 1:3) was set up: 7.7 μL 
(125 ng) pPICZ A vector, 17.8 μL (157 ng) PGT11 insert, 3μL 10X ligase buffer (Promega), and 
1.5 μL T4 DNA ligase (Promega). The reaction was mixed by pipetting and centrifuged at  
10 000 rpm for 10 seconds, after which it was incubated at 4°C for 16 hours. A 15-μL aliquot of 
the ligation mixture was used to transform TOP10 E. coli as previously described. After recovery 
of the cells from heat shock, 75- and 150-μL aliquots of transformation mixture were spread over 
Low Salt LBZeocin (25mg/L) plates (Appendix A) which were incubated for 16 hours at 37°C. 
Colonies grew too thickly on these plates for selection of single colonies, so 10- and 20-μL 
aliquots of transformation mixture were spread over fresh plates. After incubation under the 
same conditions, thinly distributed colonies were observed on these two plates. Six were selected 
and designated B1 - B6.   
Table 10. Concentrations of BW-1 PGT11 insert and pPICZ A vector following agarose gel 
band excision and purification. 
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2.15 – Sequencing of B1, B2, and B3 PGT11-pPICZ A DNA 
 Transformant colonies were PCR screened for presence of the PGT11 insert as described 
in section 2.1; however, the colonies were screened with AOX1 primers (Table 4), and reactions 
were run as in Table 3. The reactions were run on agarose (0.8%) gel as described previously. 
The six positive colonies were each inoculated into 5mL of Low Salt LBZeocin (25mg/mL) and 
incubated overnight at 37°C, 250 rpm. Glycerol stocks were prepared as before and stored at  
-80°C. As described before, DNA was extracted by miniprep from the remaining 4.5-mL cultures 
of colonies B1, B2, and B3. The DNA samples were shipped with 5μM CSP152F and 153R 
primers to the University of Tennessee’s Molecular Biology Resource Facility for sequencing. 
Samples were sequenced with 5’ and 3’ AOX1 primers and clone specific primers CSP152F  and 
CSP153R as described in section 2.10. 
 
2.16– Second attempt to correct 3’ frameshift by PCR site-directed mutagenesis 
 Because sequencing results showed that none of the plasmid DNA samples contained the 
desired insertion of two bases, a second attempt was made to correct the frameshift by inserting 
two bases using primers CSP138F and CSP154R. This time, however, the annealing temperature 
was increased. This was done to melt secondary structure in the CSP154R primer which may 
have interfered with obtaining the desired PCR product. In a second reaction, an attempt was 
made to insert eight bases using a newly designed mutagenic primer, CSP155R, whose 
secondary structure melted at a much lower temperature than the Tm of the primer (Table 11).  
 A 1:100 dilution was made of PGT11-TOPO AN-2 DNA from the miniprep described in 
section 2.10 by mixing 1 μL with 99 μL of water. The dilution was used as template for PCR. 
Reaction mixtures used in the modification reactions were (in final concentrations) 1X colorless 
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Table 13. Annealing temperatures of PCR modification reactions whose products were cloned 
into the pCR4-TOPO vector.  
GoTaq reaction buffer, 0.2 mM dNTPs (note that Promega suggests 2 mM), 1 μM in each of two 
primers, 0.1 ng template/μL, and 0.08 units GoTaq DNA polymerase/10-μL reaction (note that 
Promega recommends 0.05 U/10 μL of reaction). See PCR conditions in Tables 12 and 13 
below. A gradient of annealing temperatures was performed with 10-μL PCR reactions. To avoid 
secondary structure interference in obtaining the proper PCR product, the PCR products with the 
highest annealing temperatures were used for cloning into the pCR4-TOPO TA vector. These 
were designated 3M and 4M. CSP155R was less specific to the template DNA, hence the lower 
annealing temperature for reaction 3M. 
 
 
  
 
 
 
Rxns Primers 
Predicted 
Tm (°C) 
Hairpin 
Tm (°C) 
4M CSP154R: 5'- CCT CCG CGG CCT GCG GGC CAT TGC TTG -3' 72.8 68.4 
3M CSP155R: 5'- ATC CGC GGC CTC CTC CTG CGG GCC ATT GCT TGA T -3' 73.5 55.3 
3M and 4M CSP138F: 5'- CGG GGT ACC GCC ATG GCC ATG AGC AGT CCC CAT G -3' 72.4 44.4 
Step Temperature (°C) Time (s) No. of cycles 
Initiation 94 120 1 
Denaturation 94 30 
30 Annealing See Table 12 30 
Elongation 72 90 
Final Elongation 72 300 1 
Reaction Annealing Temperature (°C) Primers 
4M 70 CSP138F, CSP154R 
3M 64.5 CSP138F, CSP155R 
Table 11.  Melting temperatures and secondary structure melting temperatures of primers used 
in attempts to correct 3’ frameshift by inserting bases. CSP154R and CSP155R are mutagenic 3’ 
primers. CSP138F was a non-mutagenic 5’ primer used in both reactions 3M and 4M. Underlined 
bases in the mutagenic primers are complementary to the desired insertions.  
Table 12. Conditions for PCR modification reactions. 
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 The TOPO TA Cloning Kit for Sequencing (Invitrogen) was used to clone PCR products 
3M and 4M into the pCR
®
4-TOPO cloning vector. Two cloning reactions were prepared 
according to manufacturer’s directions: 4 μL of each PCR product was mixed with 1 μL of 
supplied salt solution and 1 μL of TOPO vector. The cloning reactions, designated 3M and 4M 
after the PCR products, were incubated at room temperature for 30 min. 
 
2.17 - Transformation of PGT11 3M- and PGT11 4M-TOPO into TOP-10 E. coli  
 The cloning reactions were used to transform TOP10 E. coli as described previously. 
Following recovery, 35- and 70-μL aliquots of each transformation mixture was spread over Low 
Salt LBAmp (100mg/L). The plates were incubated for 16 hours at 37°C, and eight colonies each of 
PGT11 3M-TOPO and PGT11 4M-TOPO were selected. Overnight cultures of the selected 
colonies were grown approximately 15 hours at 37°C, 250 rpm in 7 mL of Low Salt LBAmp 
(100mg/L).  
 Glycerol stocks of all 16 colonies were stored at -80 °C, and plasmid DNA was extracted 
by miniprep (as described previously) from two 3-mL aliquots of each culture. One DNA sample 
of each culture was sent for sequencing with M13 primers (complementary to TOPO vector) at 
the University of Tennessee Knoxville’s Molecular Biology Resource Facility. M13 primers are 
described in Table 14 below: 
Primer Sequence Tm (°C) 
M13 forward 5’ – GTA AAA CGA CGG CCA G – 3’ 50.7 
M13 reverse 5’ – CAG GAA ACA GCT ATG AC – 3’ 47.0 
 
 
 
Table 14. Primers used for sequencing PGT11-TOPO DNA after second attempt to correct 
frameshift. These primers were provided by the sequencing facility.  
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2.18 - Stratagene QuikChange® Site-Directed Mutagenesis for frameshift correction 
 Because the foregoing procedures were unsuccessful in correcting the 3’ frameshift by 
inserting two or eight bases within the PGT11 sequence, the QuikChange® Lightning Site-
Directed Mutagenesis Kit (Stratagene) was used to delete a single base directly from the  
PGT11 B2-pPICZ A construct.  
 E. coli containing PGT11 B2-pPICZ A DNA (see sections 2.12-2.16 for origin of clone 
B2) were inoculated into 5 mL of Low Salt LBZeocin (25 mg/L). The culture was incubated 16 hours at 
37°C, 250 rpm, and PGT11 B2-pPICZ A plasmid was extracted by miniprep as previously 
described. This plasmid DNA was used as the template for a PCR site-directed mutagenesis 
reaction using the QuikChange® Lightning Site-Directed Mutagenesis Kit. The following 
components were mixed together for a 50-μL PCR reaction mixture (“reaction 1”) in accordance 
with manufacturer’s instructions (Agilent Technologies 2007): 37.5 μL sterile milliQ H2O, 1 μL 
plasmid DNA from miniprep (44.7 ng), 5μL 10X reaction buffer from the kit, 2μL (125 ng) of 
mutagenic primer CSP165F, 2μL (125 ng) of mutagenic primer CSP166R, 1 μL of dNTP mix 
from kit, and 1.5 μL QuikSolution™. A second 50-μL mixture (“reaction 2”) was made 
similarly, using 1 μL of a 1:3 dilution of miniprep DNA rather than the miniprep DNA stock. 
The kit’s manufacturer recommends reactions with template concentrations between 10 and 100 
ng per 50-μL reaction (Agilent Technologies 2007). A 1-μL portion of Lightning Enzyme™ was 
added to each 50-μL mixture and mixed thoroughly by pipetting. Primer information is given in 
Table 15 below. Reactions 1 and 2 were run as described in Table 16.   
Primer Sequence Tm (°C) 
CSP165F  5' - GCA ATG GCC CGC ACC GCG GGG CCG CCA GCT TGG GCC CG - 3' 
81.1 
CSP166R  5' - CGG GCC CAA GCT GGC GGC CCC GCG GTG CGG GCC ATT GC - 3' 
 
 
Table 15. Mutagenic primers for correction of 3’ frameshift in PGT11 insert by whole-plasmid mutagenesis. 
These primers were purified by PAGE as recommended by the Stratagene kit manufacturers. 
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Step Temperature (°C) Time (s) No. of cycles 
Initiation 95 120 1 
Denaturing 95 20 
18 Annealing 60 10 
Elongation 68 141 (30 seconds/kb) 
Final Elongation 68 300 1 
  
 
 Following PCR, 2 μL of DpnI restriction enzyme from the kit, which selectively cleaves 
methylated template DNA, was added to each reaction and mixed thoroughly by pippetting. The 
reactions were then incubated for 1 hour at 37°C. A 10-μL aliquot of each reaction was run on 
0.8% agarose gel stained with ethidium bromide as described previously to confirm proper 
amplification. A 4-μL aliquot of each reaction was used to transform TOP10 E. coli (Invitrogen) 
as described previously in section 2.12. TOP10 E. coli were used rather than the XL1 Gold 
Supercompetent cells supplied with the kit because a prior transformation attempt with the cells 
was unsuccessful. 
 
2.19 – Transformation of TOP10 E. coli with PGT11–pPICZ A DNA corrected for 3’    
            frameshift and selection of ten transformant colonies for PCR screening 
 Following heat-shock transformation, 250 μL of Low Salt LB medium (Appendix A) was 
added to each of the two vials of cells. The vials were then shaken horizontally in an incubator-
shaker at 37 °C, 225 rpm for 75 min, after which 50- and 100-μL portions of each transformation 
mixture were plated on Low Salt LBZeocin (25mg/L) (Appendix A). The two plates spread with E. 
coli transformed with DNA from PCR site-directed mutagenesis reaction 1 were designated 5MC 
#1 and #2. Plates spread with E. coli containing DNA from reaction 2 were designated 5MD #1 
Table 16. Cycling conditions for PCR whole-plasmid mutagenesis using Stratagene QuikChange Lightning Site-
Directed Mutagenesis Kit. 
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and #2. The plates were incubated for 16 hours at 37°C, and five 5MC colonies and five 5MD 
colonies were selected. Colonies were designated 5MC-1, 5MC-2, etc. and 5MD-1, 5MD-2, etc.  
 Each colony was suspended in 100 μL of sterile milliQ water. A 50-μL aliquot of each 
cell suspension was inoculated in 7 mL of Low Salt LBZeocin (25mg/L), and the cultures were 
incubated approximately 16 hours at 37°C, 250 rpm. Glycerol stocks were prepared from each 
culture by mixing 500 μL of sterile 50% glycerol with an equal volume of culture; the glycerol 
stocks were stored at -80°C.  
 Before the cultures were left to incubate overnight, the remaining cell suspension of each 
colony was boiled for 5 min to extract DNA for PCR screening to confirm that PGT11-pPICZ A 
DNA was within the selected colonies. The following PCR master mix was prepared: 60μL 2X 
GoTaq master mix (Promega), 24 μL sterile milliQ H2O, 12 μL 10μM 5’ AOX1 primer, and  
12 μL 10μM 3’ AOX1 primer. A 9-μL aliquot of this mix was mixed with 1 μL of each boiled 
cell suspension. As a negative control, one 9-μL aliquot of master mix was mixed with 1 μL of 
sterile dH2O. The reactions were cycled as previously described (Table 3, section 2.5) and run 
on agarose gel as described prevously.       
 Using a Qiaprep™ Plasmid Miniprep Kit as described previously, plasmid DNA was 
extracted from two 3-mL aliquots of each culture. One DNA sample from each colony was sent 
for sequencing with 5’ and 3’AOX1 (vector-specific) primers at the University of Tennessee 
Molecular Biology Resource Facility. 
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2.20 - Confirmation of 3’ frameshift correction 
 Initial sequencing results revealed that all six colonies contained the deletion to correct 
the 3’ frameshift. However, not enough data were received to sequence completely through the 
PGT11 insert. Therefore, more DNA was needed for sequencing with internal primers.  
 To ensure that single colonies were selected, glycerol stocks of colonies 5MC-2, 5MC-3, 
and 5MC-4 were each streaked on a Low Salt LBZeocin 25mg/L plate, which was subsequently 
incubated 16 hours at 37°C. A single colony was selected from each plate and inoculated into  
5 mL of Low Salt LBZeocin, which was incubated for 16 hours at 37°C, 250rpm. Glycerol stocks 
of each of the three cultures were prepared as described previously and stored at -80°C. From the 
remaining 4.5 mL of each culture, plasmid DNA was extracted by miniprep and sent for 
sequencing at the University of Tennessee. Sequencing results confirmed that 5MC-2, 5MC-3, 
and 5MC-4 all contained the PGT11 sequence of clone AN-2 in the proper frame with the 3’ 
fusion tags, and 5MC-2 was selected for further work. 
 
2.21 – Midiprep of PGT11 5MC-2—pPICZ A DNA corrected for 3’ frameshift  
 Glycerol stock of E. coli containing 5MC-2 DNA was inoculated into 5 mL of Low Salt 
LBZeocin (25mg/L) and incubated ~20 hours at 37°C, 250 rpm. A 100-μL aliquot of this culture was 
used to inoculate 100 mL of fresh Low Salt LBZeocin (25mg/L), and this second culture was 
incubated 16 hours at 37°C, 250 rpm. The culture was divided into two portions and 5MC-2 
plasmid DNA was extracted from each using a QuantumPrep™ Plasmid MidiPrep Kit (Bio-Rad) 
as described in section 2.1 but with the following modification:  Plasmid DNA samples were 
eluted in 600 μL of sterile dH2O into 2-mL microfuge tubes. 
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 The concentrations of the two DNA samples were measured from 2-μL aliquots using a 
Nanodrop-1000 spectrophotometer and its accompanying computer software. Concentration 
measurements are given in Table 17 below. 
 
DNA Concentration (ng/μL) 
Total DNA in 
600-μL sample (μg) 
5MC-2 I 232.6 139.6 
5MC-2 II 197.2 118.3 
 
 
  2.22 – SacI restriction for linearization of PGT11-pPICZ A 5MC-2 DNA 
 As explained in section 2.2, it is advantageous to linearize pPICZ A constructs by 
cleavage at a single restriction site within the AOX1 promoter region before transformation into 
Pichia pastoris. The mixture described in Table 18 below was prepared in order to linearize  
PGT11 5MC-2—pPICZ A plasmid, which was corrected for the 3’ frameshift between the insert 
and fusion tags. All reaction components except for SacI (Promega) were mixed together 
thoroughly by pipetting, and SacI was added and mixed gently by pippetting. The mixture was 
microfuged at 10 000 rpm for 20 seconds and then incubated at 37°C for 4 hours.  
 
Sample 
Plasmid DNA 
(μL) 
Total Mass of DNA 
(μg) 
10X Buffer J 
(μL) 
10X BSA 
(μL) 
SacI 
(μL) 
5MC-2 300 69.8 37.88 37.88 3.00 
Note: 10X Buffer J is supplied with SacI (Promega). 10X prepared from supplied 100X BSA (Promega.) 
 
  
 After 4 hours of incubation, 3 μL more SacI was added to the reaction. The SacI was 
mixed with the reaction and centrifuged as before, then returned to 37°C overnight (~12 hours). 
Table 18. Reaction mixture of restriction digest for linearization of PGT11-pPICZ A 5MC-2 plasmid. 
Table 17. Concentrations of pPICZ A and PGT11-pPICZ A Plasmid DNA extracted from E. coli. 
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The following morning, a 1-μL aliquot of reaction mixture was diluted 1:5 by mixing it with  
4 μL of sterile dH2O. A 1-μL aliquot of undigested 5MC-2 midiprep DNA sample I was diluted 
in the same manner. A 1-μL aliquot of each 1:5 dilution was then mixed with 4μL of sterile 
dH2O and 1μL of 6X blue/orange dye (Promega). The samples were then run on agarose (0.8%) 
gel alongside 5μL of exACTGene 1kb plus DNA ladder (Fisher Scientific). The linearization 
reaction appearing complete, the SacI digestion reaction was stopped by heating at 65°C for 15 
min.  
 
2.23 - Purification and concentration of linearized PGT11 5MC-2—pPICZ A plasmid 
 DNA (chloroform-phenol extraction and ethanol precipitation) 
 To the digestion (linearization) reaction mixture, 400 μL (an equal volume) of phenol: 
chloroform: isoamyl alcohol (25:24:1) (Fisher Scientific) was added. Each sample was then 
vortexed vigorously for 30 seconds and microcentrifuged for 1 minute at 13 000 rpm. Of the top 
(aqueous) phase, 360 μL was drawn off and transferred to a fresh tube, and 36 μL (1/10 volume) 
of sterile 3M sodium acetate was added, followed by 990 μL (2.5 volumes) of ice-cold 100% 
ethanol. The sample was then inverted several times to mix and then incubated overnight in a 
 -20°C freezer. 
 The following morning, the sample was microcentrifuged at 15 000rpm, 4°C for 15 
minutes. Unlike with the previous precipitation, an off-white DNA pellet was clearly visible. The 
supernatant was carefully decanted, and the DNA pellet was washed in 250 μL of ice-cold 80% 
ethanol. The samples were then centrifuged at 15 000rpm, 4°C for 10 min. The supernatant was 
carefully decanted, and the DNA pellet was dried by inverting the tube for 15 minutes at room 
temperature on a double layer of Kimwipes (Kimberly-Clark). The pellet was then re-suspended 
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in 15 μL of sterile dH2O. A 1:20 dilution was made of the concentrated, linearized plasmid DNA 
solution by mixing 1 μL with 19 μL of sterile dH2O. The concentration of the dilution was 
determined using a 2-μL aliquot on a Nanodrop-1000 spectrophotometer: 151.5 ± 4.9 ng/μL  
(n = 4). Multiplication of the 1:20 dilution’s concentration by 20 showed that the remaining  
14 μL of concentrated, linearized plasmid DNA stock contained 3.0 ± 0.1 μg DNA/μL and 
sufficient for transformation into in Pichia pastoris.  
 
2.24 – Electroporation of P. pastoris with linearized PGT11 5MC-2—pPICZ A construct 
 As described previously, yeast cells were grown to the proper growth phase for 
electroporation; however, in this second trial, a 50-mL culture was grown to an A600 = 1.3 rather 
than 1.4. The competent yeast cells were harvested by centrifugation, but the procedure was 
slightly altered: The cells were re-suspended in less 1M sorbitol than the last trial to ensure that 
cell density was high enough for a successful electroporation. The Pichia Easy Select Kit user’s 
manual recommends re-suspending yeast from a 500 mL culture in 1 mL of 1 M sorbitol in the 
final step. Thus, the first trial’s final re-suspension of yeast from 100 mL of culture in 1 mL of  
1 M sorbitol was improperly scaled. The cells in this second electroporation would have been re-
suspended in 100 μL of 1 M sorbitol; however, two workers were sharing the cells for separate 
electroporations, and the volume was adjusted to 200 μL to ensure that there would be enough 
suspension for both. 
  The cells were centrifuged at 1500 x g for 3 min at 4°C. The supernatant was discarded, 
and the pellet was re-suspended in 50 mL of ice-cold sterile dH2O. The cells were then 
centrifuged as before, the supernatant discarded, and the pellet re-suspended in 25 mL of ice-cold 
sterile dH2O. The cells were centrifuged as before, the supernatant discarded and the pellet re-
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suspended in 4 mL of ice-cold, sterile 1 M sorbitol (sorbitol powder from Acros Organics). The 
cells were then centrifuged one final time, the supernatant discarded and the cells re-suspended 
in 200 μL of sterile, ice-cold 1 M sorbitol. This last suspension of cells was transferred to a 
sterile 1.5-mL microfuge tube and kept on ice until the electroporation less than 30 min later. 
 An 80-μL portion of the yeast suspension was mixed with 14 μL of remaining linearized, 
concentrated PGT11 5MC-2– pPICZ A DNA, and the mixture was transferred to an 
electroporation cuvette on ice (Bio-Rad GenePulser). The cuvette was incubated on ice an 
additional five minutes, after which it was pulsed on manual setting at 1.50 kV in a Bio-Rad 
MicroPulser™. Immediately after pulsing, 1 mL of ice-cold, sterile 1 M sorbitol was added to 
the cuvette. Next, the entire content of the cuvette was transferred to a sterile, 15-mL 
polypropylene tube and incubated at 30°C for 90 min without shaking. Following the incubation, 
25-, 50-, 100-, and 200-μL aliquots were plated on YPDSZeocin (100mg/L) plates (Appendix A). The 
remaining cells were stored at 4°C. 
 The plates were incubated at 28°C for 72 hours. Over 100 colonies were present on the 
four plates after incubation. Twelve colonies were selected and re-streaked on YPDSZeocin (100mg/L) 
plates (Appendix A) and incubated at 28°C for 60 hours. 
 
2.25 – PCR screening of P. pastoris colonies transformed with PGT11 expression 
 construct corrected for frameshift (PGT11 5MC-2—pPICZ A) 
 A single colony from each of the 12 re-streaked transformant colonies was re-suspended 
in 20 μL of sterile dH2O. Half of each yeast suspension was transferred to a new tube and stored 
at 4°C. The cells of the remaining 10 μL of suspension were lysed to extract template for PCR 
(Life Technolgies 2011): A 5-μL aliquot of lyticase (5 u/μL) (lyophilized powder from Sigma-
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Aldrich) was mixed with each cell suspension and incubated at 30°C for 15 minutes. The cell 
suspensions were frozen at -80°C for 10 minutes. 
 The following PCR master mix was prepared: 85 μL 2X GoTaq master mix (Promega), 
17 μL 10 μM CSP138F primer, 17 μL 10 μM CSP139R primer, and 17 μL sterile dH2O. An 8-
μL aliquot of master mix was mixed with 2 μL of each cell lysate. As a negative control, 2 μL of 
sterile dH2O was mixed with 8 μL of master mix. As positive controls, 8-μL aliquots of master 
mix and 1 μL of sterile dH2O were mixed with each of the following: 1 μL of a 1:5 dilution of 
5MC-2 midiprep DNA, 1 μL of a 1:10 dilution of midiprep, and 1 μL of a 1:20 dilution. Primers 
used in the PCR screen were complementary to the ends of the PGT11 insert and are described in 
Table 19 below. PCR conditions are given in Table 20. 
Primer Sequence Tm (°C) 
CSP 138F 5’-CGG GGT ACC GCC ATG GCC ATG AGC AGT CCC CAT GTT GTG-3’  72.4 
CSP 139R 5'- CCT CCG CGG TGC GGG CCA TTG CTT G -3' 70.4 
 
 
Step Temperature (°C) Time (s) No. of cycles 
Initiation 95 120 1 
Denaturing 95 30 
30 Annealing 65 30 
Elongation 72 120 
Final Elongation 72 300 1 
 
 
 
2.26 – Test Inductions of recombinant enzyme in PGT11 5MC-2–p PICZ A transformants 
 All twelve colonies screened gave PCR product that matched the expected size of 
PGT11. Colonies 1 through 4 were re-streaked again to ensure the use of single colonies for test 
inductions of recombinant PGT11. The plates were incubated for 48 hours at 28°C, after which a 
Table 19. Primers used for PCR screening of PGT11 5MC-2—pPICZ A transformants, designed by 
Wamucho (2012). 
Table 20. PCR conditions for screening of PGT11 5MC-2—pPICZ A transformants. 
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single colony from each plate was inoculated into 30 mL of BMGY medium (Appendix A) in a 
125-mL Erlenmeyer flask. The cultures were incubated for 22 hours until they reached the 
following absorbance values: 
Colony A600 
1 2.21 
2 2.10 
3 1.34 
4 1.79 
   
  
 The colonies were harvested and re-suspended in BMMY as in section 2.6; however, the 
cells were washed in only 30 mL of BMMY. After washing, the cells were centrifuged as before 
and re-suspended in BMMY to the following A600 values.  
 
Colony A600 
1 1.31 
2 1.22 
3 1.10 
4 1.17 
  
 
 
 Two 1-mL samples were taken from each re-suspension in BMMY to represent pre-
induction conditions. A 50-mL aliquot of each culture was placed in a 250-mL Erlenmeyer flask 
and incubated at 30°C for four days, adding 100% methanol to a final concentration of 0.5% 
every 24 hours to maintain induction conditions. (See section 2.6 for a discussion of how 
methanol induces expression.) Two 1-mL samples were taken at intervals throughout a 96-hour 
Table 21. Optical densities of transformant yeast cultures grown in 
BMGY to generate biomass for induction. 
Table 22. Optical densities of transformant yeast cultures 
in BMMY at induction time zero. 
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time course as described previously. Pre- and post-induction samples were processed as 
described in section 2.6 and saved at -80°C for later analysis by SDS-PAGE and Western blot. 
 Protein was extracted from pre- and post-induction cell pellets as described previously, 
using 100 μL of breaking buffer (Appendix B).  Dilutions were prepared for each protein sample 
by adding 2 μL of sample to 18 μL of breaking buffer. Concentrations were determined as 
described previously. A 70-μg portion of 0 to 12 h samples of colonies 1 through 4 and 18 h 
samples for colonies 1 and 2 were prepared and loaded into a polyacrylamide gel as described 
previously. A duplicate gel was prepared; one gel was stained with Coomassie blue and one was 
used for Western blot. Recipes for all solutions and buffers used for SDS-PAGE and Western 
blot are in Appendix B. 
 Western blot was repeated as before (section 2.9) with one modification: between 
blocking and primary antibody solutions, the membrane was rinsed for 5 min with TBS 
containing 0.02% sodium azide to remove excess milk proteins. The membrane was developed 
for approximately 20 seconds in alkaline phosphatase substrate solution before stopping the 
reaction with 2mM EDTA. Subsequently, four Western blots of the full 96-hour time course 
were done, one for each colony 1 - 4. A 64-μg portion of each induction sample was loaded per 
well in all four gels for Western blot. Each gel used for Western blot was duplicated for 
Coomassie staining. 
 
2.27 – Scale up of expression of recombinant PGT11 (rPGT11) 
 Based on the analysis of induction samples, colony 3 at 12 hours was chosen for scale up 
of expression. Colony 3 was re-streaked on a YPDZeocin 100mg/L (Appendix A) and incubated at 
28°C for 2 days. A single colony was used to inoculate 50 mL of BMGY (Appendix A) in a 250-
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mL flask, and the culture was allowed to grow for 24 hours to A600 = 2.9. The culture was 
divided into two samples which were centrifuged for 5 min at room temperature, 3000 x g to 
harvest the cells. The cell pellets were each re-suspended in 30 mL of BMMY (Appendix A) to 
rinse away carbohydrates that could inhibit induction by the AOX1 promoter. The samples were 
centrifuged as before, and the cell pellets were re-suspended in a combined volume of 100 mL of 
BMMY. 
 The A600 was adjusted to 1.08 by pouring off cell suspension and adding pure BMMY to 
dilute the cells. When the desired density was reached, the cells were incubated for 12 hours at 
28°C, 250rpm. The yeast cells were harvested at the end of incubation by centrifuging for 5 min 
at room temperature, 3000 x g. The cells were frozen at -80°C overnight for PGT11 enrichment 
the following morning.  
  
2.28 – Extraction, desalting, and enrichment of rPGT11  
 Each cell pellet was re-suspended in 3 mL of ice-cold breaking buffer (Appendix B) with 
5mM βME (Fisher Scientific). Cells were lysed using a French press (4 times at 1250psi 
[8600kPa]), and the lysed cells were collected on ice. The lysed cells were centrifiuged for  
20 min at 4°C, 13 000 x g. The supernatant was decanted into a fresh tube on ice and the pellet 
was discarded.  
 The protein was desalted at 4°C using a pre-packed PD-10 column which had been 
equilibrated with 25 mL of equilibration/wash buffer (Appendix B). A volume of 2.5 mL of 
supernatant was added to the column. The first 2.5 mL of flowthrough was discarded. A 3.5-mL 
portion of equilibration/wash buffer was added to the column and the next 3.5 mL of eluate was 
collected. After eluate collection, the column was equilibrated again by washing with 25 mL of 
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equilibration/wash buffer, and another 2.5 mL of crude yeast protein was processed in the same 
manner. 
 The total of 7 mL collected from the PD-10 column was enriched using a TALON IMAC 
cobalt resin column with a 4-mL bed volume at 4°C. The column was equilibrated with 40 mL of 
equilibration/wash buffer containing 5 mM βME, after which the desalted sample was applied to 
the column. The flow rate was slow (approximately 0.3 mL/min or 1 drop every 10 seconds) so 
that rPGT11 could bind to the column. The flow through was discarded, and the column was 
rinsed with equilibration/wash buffer, collecting 2-mL fractions until the A280 reached zero (ten 
fractions labeled W1 – W10). To elute recombinant PGT11, the column was washed with 20 mL 
of elution buffer (Appendix B) containing 5 mM βME, collecting ten 2-mL fractions.   
 Aliquots of 45-μL of each of the IMAC wash and elution fractions were saved for later 
analysis by SDS-PAGE and Western blot as described previously; however, 15 μL of each 
sample was loaded per well rather than an equal mass of protein. Elution fractions 1 – 5 were 
pooled together, and concentrated using a Centricon-30 (Millipore, 30-kDa molecular weight 
cutoff). The sample was centrifuged for 10 minutes at 4°C, 4000 x g to reduce its volume to 
approximately 500 μL. After re-suspending the sample to a final volume of 2 mL with 50 mM 
phosphate buffer (pH=7.5) containing 14 mM βME, the sample was centrifuged as before for an 
additional 10 min. After this second centrifugation, the enriched enzyme was again re-suspended 
in 50 mM phosphate buffer (pH=7.5) containing 5 mM βME to a final volume of 2 mL, which 
was transferred to a 2-mL microcentrifuge tube on ice. 
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2.29 – Flavonoid GT activity screening of enriched rPGT11 
 The method for screening recombinant PGT11 (rPGT11) for flavonoid GT activity was 
an adaptation of McIntosh et al (1990). Each reaction contained 50 nmol of flavonoid substrate 
dissolved in 5 μL of ethylene glycol monomethylether, 50 μL of 50 mM phosphate buffer 
(pH=7.5) (Appendix B) containing 14 mM βME, 10 μL of  
14
C-UDP-glucose (20 000 cpm/10μL) 
in 50 mM phosphate buffer (stock 
14
C-UDP-glucose [261 mCi/m mol] was purchased from 
ICN), and 10 μL of enriched rPGT11. The reactions were incubated for 5 min at 37°C and were 
stopped by adding 15 μL of 6 M HCl and vortexing for 5 seconds. Each reaction was performed 
in duplicate. A set of time zero reactions were prepared. These were prepared and incubated in 
the same manner as the 5 min reactions, but 15 μL of 6 M HCl was added before the enzyme. 
Time zero reactions were also performed in duplicate. After stopping the reactions, the flavonoid 
content of each reaction, including any glucoside products, was extracted by adding 250 μL of 
ethyl acetate (Fisher Scientific) and vortexing for 15 seconds. A 150-μL aliquot of the ethyl 
acetate (top) layer was added to 2 mL of Cyto-Scint scintillation fluid and counted in a Beckman 
LS 6500 scintillation counter. The measured cpm incorporated was multiplied by  
250μL/150μL = 1.667 to account for counting only 150 μL of the 250 μL of the ethyl acetate 
layer. 
 As a negative control, denatured rPGT11 was used; rPGT11 was denatured by boiling for 
5 minutes in a water bath. As a positive control, 60 μL of young Duncan grapefruit leaf extract 
was used in place of 10 μL of enzyme and 50 μL of 50mM phosphate buffer. (The grapefruit leaf 
extract was prepared by grinding approximately 1 g of young grapefruit leaf tissue in 25 mL of 
50 mM phosphate buffer with 14 mM βME.) A second positive control was done by using 50 μL 
of grapefruit extract in place of 50 mM phosphate buffer, but 10 μL of rPGT11 was also used. 
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This second positive control was done to see any inhibitory effects of the concentrated enzyme 
on the reaction. The flavonoid substrates used for the enzyme assay are listed with their 
molecular weights and structures in Table 23 below.  
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Class of substrate Name of substrate 
 
Structure 
Molecular weight 
(Mr) 
Flavanone 
Naringenin 
 
272.25 
Hesperitin 
 
302.2 
Eriodictyol 
 
288.25 
Isosakuranetin 
 
286.28 
Flavone 
Apigenin 
 
270.25 
Luteolin 
 
286.28 
Diosmetin 
 
300.26 
Scutellarein 
 
286.24 
CH3 
47 
 
Flavonol 
Kaempferol 
 
286.24 
Quercetin 
 
338.3 
Fisetin 
 
286.24 
Gossypetin 
 
318.14 
4’-Methoxyflavonol 
 
268.27 
Isoflavone 
4’-acetoxy-7-hydroxy-6-
methoxyisoflavone 
 
326.31 
  
 
 
  
Table 23. Flavonoid substrates used for GT activity screening. 
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3. Results 
3.1 – Attempt to express rPGT11 using PGT11 D-pPICZ A plasmid 
 PGT11 D-pPICZ A DNA was extracted from Anye Wamucho’s E. coli colony D by 
midiprep and linearized by restriction digest with SacI. Figure 4 confirms that the DNA was 
sufficiently linearized for purification, concentration, and transformation into Pichia pastoris. 
(Non-linearized plasmid would result in multiple bands because linear and circular DNA migrate 
differently.) Empty vector was also extracted from E. coli and linearized as a negative control.  
  
 Linearized DNA was purified by phenol:chloroform extraction and ethanol precipitation. 
Aliquots of 1 and 2 μL of 1:20 dilutions of each concentrated stock were run on agarose gel 
alongside exACTGene 1kb plus DNA ladder (Figure 5). The brightness of the band 
corresponding to 1 μL of 1:20 dilution appeared much more intense than the 43- and 41-ng bands 
of the quantitative DNA ladder exACTGene 1kb plus DNA ladder. Thus, the concentration of 
the remaining 9 μL of stock PGT11-pPICZ A DNA was greater than 43 ng/μL x 20 = 860 ng/uL 
(>7.74 μg in 9μL) and was deemed sufficient for transformation into P. pastoris; the exact 
concentration, however, was not determined. The pPICZ A vector’s user manual recommends 5 
Figure 4. Confirmation of linearization of 
PGT11 D-pPICZ A DNA with SacI for 
electroporation of P. pasotris.  Agarose (0.8%) 
gel stained with ethidium bromide.   
 
M is 10μL of exACTGene 1kb plus DNA ladder.  
 
PG (from left to right, samples PG1 and PG2): 
PGT11 D-pPICZ A (PGT11 D insert in pPICZ A 
vector). 
 
PA (from left to right, samples PA1 and PA2): 
empty pPICZ A vector (no PGT11 D insert). 
 
All PG and PA lanes represent 2-μL aliquots from 
each digestion reaction.  
  
M PG PA 
4.7kb 
3.3kb 
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to 10 μg of linearized DNA in a volume of 5 to 10 μL for transformation (Life Technologies 
2011).  
  
 
 
 
  
 
 
 The concentrated, linearized DNA from sample PG2 was used to transform Pichia 
pastoris by electroporation, and six transformant colonies (A through F) were tested for the 
presence of PGT11 by PCR screen with AOX1 primers complementary to the pPICZ A vector. 
Results showed that PCR reactions using cell lysate as template produced a PCR product of the 
expected size for all six colonies (Figure 6); thus, it appeared that all the colonies contained the 
PGT11 D-pPICZ A construct within their genome.  
 
 
 
 
 
 
 
Figure 6. PCR screen of P. pastoris colonies transformed with PGT11 D-pPICZ A DNA. M is 10μL 
exACTGene 1kb plus DNA ladder. The positive and negative controls (+) and (-) are reactions using 
plasmid DNA isolated from E. coli as the template. Positive control used PGT11 D-pPICZ A as template 
(1700-bp product = 300bp of vector + 1400bp of PGT11 insert). Negative control used pPICZ A (empty 
vector) as template (300-bp product = 300 bp of vector). A through F are PCR reactions using cell lysate 
from transformant Pichia colonies A through F as template.   
M PG1 PA1 
4.7kb 
3.3kb 
PG2 PA2 
10μL 1μL 2μL 1μL 2μL 1μL 2μL 1μL 2μL 
Figure 5. Confirmation of sufficient concentration of linearized PGT11 D-pPICZ A 
DNA for transformation of Pichia pastoris. PG1 and 2: pPICZ A with PGT11 insert. 
PA1 and 2: pPICZ A (no insert). The band for 1 μL of sample PG2 was compared to the 
quantitative marker M (exACTGene 1kb plus DNA ladder).    
 
43ng 
41ng 
Volume of 1:20 dilution: 
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 Because colonies appeared to contain PGT11-pPICZ A expression construct, expression 
of recombinant PGT11 enzyme was induced in BMMY (methanol complex medium). (See 
section 2.6 for a discussion of how methanol induces expression.) Western blot analysis of 
induction protein samples did not show any expression of recombinant PGT11 protein (Figure 
7). Overall protein expression pattern in colony F is shown in Figure 8; before duplicate gels of 
A and B were done, a frameshift was discovered which prevented expression of PGT11 in frame 
with the fusion tag used for detection.  
 
 
  
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 7. Western blots of induction time course 
of PGT11 D-pPICZ A P. pastoris colonies A, B, 
and F. M is Bio-Rad pre-stained low range size 
standard. Each sample in A and B contained 50μg 
protein; each sample in F contained 9.9μg. Primary 
antibody was mouse monoclonal anti-c-myc. 
Secondary antibody was goat anti-mouse IgG-AP. 
Membranes were developed for over 20 minutes.  
0 to 72h post-induction M 
F A 
B 
0 to 96h post-induction M 
Figure 8. Silver stain of PGT11 D-pPICZ A P. 
pastoris colony F induction time course samples. 
Expected size of recombinant PGT11 is 55kDa.    
M 0h 6h 12h 18h 24h 48h 72h 96h 36h 
22 
31 
66 
97 
kDa 
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3.2 – Discovery of a 3’ frameshift in PGT11 D-pPICZA and discovery of PGT11 clones  
         AN-1, AN-2, and AN-3 
 Because recombinant PGT11 could not be detected by Western blot using antibodies 
against the c-myc epitope, expected in the fusion tags of the recombinant enzyme, the PGT11 D-
pPICZ A plasmid which had been used to transform P. pastoris was sent for sequencing to check 
for cloning errors. Sequencing results revealed a frameshift due to a single extra nucleotide 
between the 3’ end of the PGT11 sequence and the sequence of the fusion tag used for detection 
by Western blot and purification by ion affinity (Figure 9). 
 
 
 
 
  
  
  
  
  
 
  
 Subsequent sequencing of Anye Wamucho’s (Wamucho 2012) modified PGT11 clones 
in the pCR®4-TOPO cloning vector revealed three different clones, all of which varied slightly 
from the harvEST database PGT11 contig sequence and with each other (Tables 24 and 25). 
These three clones were designated PGT11 AN-1, PGT11 AN-2, and PGT11 AN-3. Comparison 
Figure 9. Alignment of frameshifted PGT11 D sequence and a corrected sequence from 
which one nucleotide has been deleted. The base highlighted in red was the one deleted using 
whole-plasmid PCR site-directed mutagenesis.    
 
c-myc epitope 
(detection) 
 
polyhistidine tag 
(purification) 
 
PGT11 D 
Corrected 
PGT11 D 
Corrected 
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of PGT11 D-pPICZ A and the PGT11 AN-TOPO clones confirmed that Wamucho (2012) cloned 
AN-1 into pPICZ A for expression in yeast. Of the three clones, AN-2 had the fewest amino acid 
differences with the translation of the PGT11 contig sequence from the harvEST database 
(Mallampalli 2009) and was selected for cloning into the pPICZ A vector and correction of the 3’ 
frameshift in order to express recombinant enzyme in yeast. 
Nucleotide – Position 
in harvEST PGT11 
contig sequence  
AN-1 (PGT11 D) AN-2 (PGT11 5MC-2) AN-3 
G–311 A A A 
A–581 G G G 
G–647 same 
same 
A 
A–939  
deleted 
same 
A–940 
A–941 
T–942 
G–943 
A–944 G 
T–945 
same G–946 
C–947 
T–1018 G G G 
G–1187 A A A 
 
 
 
 
 
 
 
Table 24. Comparison of the DNA sequences of clones AN-1, AN-2, and AN-3 to the harvEST 
database contig sequence of PGT11. Underlined nucleotide codes are differences common to all three 
AN clones. AN-1 matches the Wamucho (2012)’s PGT11 clone D in pPICZ A. AN-2 was selected for 
further work.  
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PGT11 (harvEST)  AN-1 (PGT11 D) AN-2 (PGT11 5MC-2) AN-3 
G104 E E E 
Q194 R R R 
C216 same same Y 
N314 
deleted 
same same 
D315 same G 
A316 same same 
F340 V V V 
R396 K K K 
 
 
 
3.3 – Cloning of PGT11 AN-2 into the pPICZ A vector for expression in yeast and attempt  
          to correct 3’ frameshift by PCR modification 
 PGT11 was amplified from the AN-2–TOPO plasmid with mutagenic primers in an 
attempt to insert two bases at the 3’ end of the PGT11. The presumptively modified PGT11 
product was TA cloned into the pCR®4-TOPO vector, and the resultant plasmid (designated 
BW) was transformed into TOP10 E. coli. Plasmid DNA was isolated from transformant colony 
BW-1 by miniprep. A 1-μg sample of BW-1 plasmid and an equal mass of pPICZ A DNA was 
cut with KpnI and SacII restriction enzymes. The appropriate DNA fragments (1.3-kb PGT11 
band and 3.3-kb pPICZ A band) were gel purified and ligated together (Figure 10). The resultant 
plasmid was transformed into TOP10 E. coli.  
 
 
 
 
Table 25. Comparison of translations of clones AN-1, AN-2, and AN-3 to a translation of the 
harvEST database PGT11 contig sequence. Underlined amino acid codes are differences common to 
all three AN clones. 
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Undg  Undg  KpnI  SacII  
KpnI 
and 
SacII 
KpnI 
and 
SacII 
PGT11 BW-1–TOPO  pPICZ A  
Figure 10. Digestions of BW-1–TOPO and pPICZ A 
plasmid DNA for ligation of AN-2 insert into 
pPICZA. Bands outlined with black boxes were gel-
purified and ligated together to insert the PGT11 
AN-2 clone into the pPICZ A vector. Undg: 
undigested plasmid. KpnI: plasmid digested with KpnI 
enzyme. SacII: plasmid digested with SacII enzyme. 
KpnI and SacII: plasmid digested with both enzymes.  
100 ng  1μg  100 ng  
DNA  
per lane:  
 
 3.3kb   
1.4kb   
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 Plasmid DNA isolated from transformants by miniprep was sent for sequencing. 
Sequencing results showed that none of the plasmid DNA samples contained the expected two-
base insertion for repair of the frameshift (Figure 11); however, the sequencing results did show 
that clone PGT11 AN-2 was now within pPICZ A. The frameshift in one of these plasmids, 
PGT11 B2-pPICZ A, would later be repaired by deletion of a single base using whole-plasmid, 
PCR site-directed mutagenesis. 
 
 
 
 
 
3.4 – Attempt to correct 3’ frameshift by PCR modification to insert bases 
 In a second attempt to correct the frameshift, a new 3’ mutagenic primer (CSP155R) was 
designed to insert eight bases. It was thought that secondary structure of the primers could be 
interfering with obtaining the desired PCR product. Therefore, a gradient of annealing 
temperatures were used, and the products formed with the highest annealing temperatures were 
used because secondary structure was more likely to be melted. In addition, the primer 
previously designed to insert two bases (CSP154R) was used in separate reactions with higher 
annealing temperatures than attempted before.  
Figure 11. Alignment of plasmid PGT11 B2-pPICZ A sequence and its predicted sequence. 
Alignment shows only the 3’ end of the PGT11 insert and the fusion tag sequence. The two base pairs 
highlighted in red are the expected insertion. 
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 The PCR products were cloned into pCR®4-TOPO, and the resultant PGT11-TOPO 
plasmids were transformed into TOP10 E. coli. Sequencing of plasmid DNA isolated from 
transformant colonies, however, revealed that insertions of neither two nor eight bases had been 
incorporated into the PCR products (data not shown).      
 
3.5 - Correction of 3’ frameshift by whole-plasmid site-directed mutagenesis 
 Because previous attempts to correct the 3’ frameshift in PGT11 by insertion of bases 
were unsuccessful, additional mutagenic primers were designed. These primers and a 
QuikChange Lightning Site-Directed Mutagenesis Kit (Stratagene) were used to delete a single 
base. Having generated mutant plasmid by PCR, the methylated template was digested using 
DpnI, and the remaining mutant plasmid was transformed into TOP10 E. coli. Sequencing of 
plasmid isolated from transformant colonies 5MC-2, 5MC-3, and 5MC-4 confirmed that the 
frameshift was corrected as depicted previously in Figure 9 and in Figure 12 on the following 
page. 
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3.6 – Test inductions of recombinant PGT11 (5MC-2), SDS-PAGE, and Western blot  
          analysis 
 Recombinant PGT11 was induced by culturing four colonies of Pichia pastoris 
containing the expression vector with PGT11 insert in the methanol complex medium BMMY. 
B 
Figure 12. Alignment of PGT 11-pPICZ A 5MC-2 sequencing data with PGT 11 sequence from harvEST 
database. A: 5’ alignment.  B: 3’ alignment. One-letter amino acid translations are given below each DNA 
sequence.  Gray highlights: KpnI (5’) and SacII (3’) restriction sites.  Green: yeast consensus sequence.  
Turquoise: PGT11 sequence.  Pink: c-myc epitope.  Yellow:  polyhistidine tag. Restriction sites and yeast 
consensus sequence were added to the ends of PGT11 by Wamucho (2012).   
A 
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Cell pellet samples were collected over a time course of four days. Crude protein was extracted 
from the cell pellets, and 75μg of each protein sample was run on a 10% polyacrylamide gel. An 
equal amount of protein was loaded for each sample so that the Western blot could show a semi-
quantitative comparison of expression levels. The Western blot was performed with antibodies 
against the c-myc epitope in the C-terminal fusion tag and developed in an alkaline NBT/BCIP 
substrate solution (Figure 13). From the results of the preliminary Western blot, colony 3 
appeared to have the highest expression of any colony at any of the time points represented, and 
colony 1 appeared to have the lowest expression of the 12 h samples.  
 
 
 
   
 
 
 
 
 
 The Western blot was repeated with fresh protein extract (66μg of each sample) (Figure 
14 below). All induction samples (0 to 96h) were run over a total of four Western blots. Samples 
of colonies 1 and 3 at 12h were included on all the blots in order to determine relative levels of 
expression between them. Blots 1 and 2 show that colony 3 at 12 hours had higher expression 
than colony 1 and 2 at any other time point. Blot 3 shows that colony 3 had the highest levels of 
expression from 12 to 48h. Blot 4 shows that colony 4 had the highest levels of expression from 
12 to 48h, and colony 4 at 12 h appears to have higher expression than colony 3 at 12 h. 
Figure 13. Preliminary Western blot of PGT11 5MC-2 Pichia colony induction samples. Membrane was 
developed under 20 seconds.    
kDa 
97 
66 
0h 
55kDa 
Colony: 1 3 2 4 1 3 2 4 1 2 
6h 12h 
45 
31 
22 
14 
18h 
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Although this disagrees with the result of the preliminary Western blot (Figure 13), which 
showed higher expression for colony 3 at 12 h, detection is only semi-quantitative. Based on 
these results, colony 3 at 12h was chosen for scale-up of expression of recombinant PGT11. 
Duplicate gels stained with Coomassie blue show the overall protein expression pattern during 
induction (Figure 15); it is difficult to distinguish rPGT11 (55kDa) from proteins of similar 
molecular weight.  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
0h 6h 12h 18h 24h 48h 72h 96h 36h 12h 
 1 3 
kDa 
97 
66 
55kDa 
45 
31 
22 
14 
0h 6h 12h 18h 24h 72h 96h 36h 12h 
2 3 
97 
66 
45 
31 
22 
14 
55kDa 
12h 48h 
1 
 Colony: 
 Colony: 
1 
2 
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 Colony: 
0h 6h 12h 18h 24h 96h 36h 12h 
3 
48h 
1 
72h 
14 
22 
31 
45 
66 
97 
55kDa 
kDa 
0h 6h 12h 18h 24h 36h 48h 72h 96h 12h 
55kDa 
 Colony: 4 3 1 
12h 
14 
22 
31 
45 
66 
97 
Figure 14. Western blots of full 96-hour time courses for colonies 1 
through 4. The 12-hour samples from colonies 1 and 3 were included on 
all four blots to determine relative levels of expression between them.  
4 
3 
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P 
1 
2 
97 
66 
45 
31 
22 
14 
97 
66 
45 
31 
22 
14 
97 
66 
45 
31 
22 
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0h 6h 12h 18h 24h 36h 48h 72h 96h 12h 
0h 6h 12h 18h 24h 36h 48h 72h 96h 12h 12h 
0h 6h 12h 18h 
Colony: 1 2 4 1 2 4 1 2 3 3 3 4 1 2 
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55kDa 
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3.7 – Scale-up of expression and enrichment of recombinant PGT11 
 Expression of rPGT11 was scaled up to a 100-mL culture which was harvested 12 hours 
after induction with methanol. Protein was extracted by French press, desalted, enriched by  
cobalt IMAC, and concentrated and dialyzed by centrifugal filtration with a 30-kDa filter. After 
3 
4 
97 
66 
45 
31 
22 
14 
97 
66 
45 
31 
22 
14 
Figure 15. Coomassie stained duplicates of gels used for Western 
blot analysis of induction samples.  
0h 6h 12h 18h 24h 36h 48h 72h 96h 12h 
0h 6h 12h 18h 24h 36h 48h 72h 96h 12h 12h 
3 1  Colony: 
4 3 1  Colony: 
55kDa 
55kDa 
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the activity screening, aliquots of washes, elutions, and enriched enzyme were analyzed to 
confirm that the proper elution fractions were concentrated for activity screening (Figure 16). It 
was confirmed that the fractions containing the most rPGT11 had been pooled and concentrated 
for flavonoid GT activity screening.  
 
 
 
 
 
 
 
   
 
 
 
 
 
 
97 
66 
45 
31 
22 
14 
97 
66 
45 
31 
22 
14 
W1 W2 W3 E1 E2 E3 E4 E5 
E6-E10 
Z 
W1 - W3 
E1 E2 E3 E4 
E6 - E10 
Z 
A 
B 
E5 
Figure 16. Enrichment of rPGT11 by IMAC. A: Coomassie-stained 
SDS-PAGE; arrow indicates rPGT11. B: Western blot with antibodies 
against the c-myc epitope. W1 – W3: The first three of ten 2-mL wash 
fractions of impure proteins; A280 in the final wash was 0.0. E1 – E10: 
Ten 2-mL elutions of enriched rPGT11 with 150 mM imidazole.  
Z: pooled, dialyzed, and concentrated fractions E1-E5. 
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3.8 – GT activity screening 
 The enriched rPGT11 was screened for GT activity by measuring incorporation of  
14
C-glucose from 
14
C-UPD-glucose (sugar donor substrate) into the products of reactions with 
flavonoid substrates. Little to no activity was detected with any of the substrates screened (Table 
26). Two substrates showed high average incorporation but had inconsistent duplicates. These 
should be tested again.     
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Class of 
Substrate 
Structure Name of Substrate 
cpm 
incorporated 
0 min (n=2) 
(avg ±SD) 
cpm 
incorporated 
5 min (n=2) 
(avg ±SD) 
Net cpm 
incorporated 
(5min – 0min) 
Flavanone 
 
Naringenin 
4’=5=7=OH 
180 (2) 182 (21) 2 
 
Hesperetin 
3’=5=7=OH, 4’=OCH3 
163 (5) 165 (64) 2 
 
Eriodictyol 
3’=4’=5=7=OH 
172 (26) 163 (25) -9 
 
Isosakuranetin 
5=7=OH, 4’=OCH3 
191 (46) 193 (25) 2 
Flavone 
 
Apigenin 
4’=5=7=OH 
155 (5) 184 (46) 29 
 
Luteolin 
3’=4’=5=7=OH 
183 (8) 164 (18) -18 
 
Diosmetin 
3’=5=7=OH, 4’=OCH3 
166 (58) 162 (26) -4 
 
Scutallerein 
4’=5=6=7=OH 
141 (4) 163 (14) 23 
CH3 
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Flavonol 
 
Kaempferol 
5=7=4’=OH 
157 (2) 157 (31) 0 
 
Quercetin 
3’=4’=5=7=OH 
213 (6) 188 (18) -25 
 
Fisetin 
4’=5’=7=OH 
176 (34) 138 (37) -38 
 
Gossypetin
3’=4’=5=7=8=OH 
163 (47) 1202 (1424) 1038 
 
4’-Methoxyflavonol 
4’=OCH3 
221 (58) 173 (11) -48 
Isoflavone 
 
4’-acetoxy-7-hydroxy-
6-methoxy isoflavone 
188 (28) 2554 (3358) 2366 
 
 
 
 Two positive controls were done, one with young grapefruit leaf extract as a flavonoid 
glucosyltransferase source and one with both grapefruit leaf extract and enriched rPGT11. Low 
activity was observed with the grapefruit leaf extract alone; however, the control including both 
Table 26. Flavonoid GT activity screening results. Each reaction contained 20 000 cpm and was performed in 
duplicate. Results printed in red had inconsistent duplicates and should be repeated. Reactions were incubated at 
37°C for 5 min.  
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grapefruit extract and rPGT11 had higher activity than rPGT11 with any of the substrates 
screened (Table 27). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Control 
cpm incorporated (0 min) 
(n=2) 
(Avg ± S.D.) 
cpm incorporated (5 min) 
(n=2) 
(Avg ± S.D.) 
Net cpm 
incorporated 
(5min – 0min) 
Grapefruit 
Extract 
+ 
Quercetin 
213 (6) 
295 (52) 82 
Grapefruit 
Extract 
+ 
Quercetin 
 + 
rPGT11 
331 (13) 118 
 
Boiled rPGT11 
 
205 (40) -8 
Table 27. Flavonoid GT activity screening control reactions. Each reaction contained 20 000 cpm and was 
performed in duplicate. Reactions were incubated at 37°C for 5 min.  
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4. Discussion 
4.1 – Attempt to express rPGT11 using the PGT11 D-pPICZ A construct 
 PGT11 was mined from the harvEST database and identified as a putative secondary 
product glucosyltransferase based on the presence of the PSPG box consensus motif 
(Mallampalli 2009) (Figure 3). Mallampalli (2009) amplified the gene from grapefruit cDNA 
and cloned it into the pCR4-TOPO vector. Subsequently, Wamucho (2012) cloned PGT11 into 
the pPICZ A vector for expression in yeast. 
 In this work, Wamucho’s PGT11-pPICZ A construct was isolated from his E. coli colony 
D. The PGT11 D-pPICZ A DNA was linearized by SacI digestion (Figure 4), purified by 
phenol-chloroform extraction, concentrated by ethanol precipitation (Figure 5), and transformed 
into P. pastoris by electroporation (Figure 6). All colonies screened with primers 
complementary to vector sequence on either side of the PGT11 insert gave PCR products of the 
expected size; a frameshift in the sequence due to a single extra base pair (as was later 
discovered) is not detectable in PCR products of this size.    
 Attempts were made to induce expression of recombinant PGT11 (rPGT11) with 
methanol under control of the Pichia AOX1 promoter; however, expression was not detected by 
Western blot (Figure 7). When expression was not detected, PGT11 D-pPICZ A plasmid which 
had been used to transform P. pastoris was sent for sequencing to check for cloning errors. A 
frameshift was discovered between the 3’ end of the PGT11 insert and the sequence of the fusion 
tags used for detection and purification (Figure 9); it is likely that recombinant PGT11 was 
expressed but was not detected because the sequence of the tag used for detection was out of 
frame with the PGT11 gene sequence.     
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4.2 – Discovery of three distinct PGT11 clones (AN-1, AN-2, and AN-3) 
 After discovery of the frameshift, other PGT11 clones (AN-1, AN-2, and AN-3) in the 
PCR4-TOPO vector were sent for sequencing. All three clones differed slightly with each other 
and with the harvEST database PGT11 contig (Tables 24 and 25). The differences among the 
clones may result from varying paralogs, isoforms, and/or polymorphisms of PGT11 in 
grapefruit. Grapefruit is a hybrid of species, and polyploid genetics may further complicate this 
issue. Differences between the AN clones and the harvEST database contig sequence are not 
surprising, as the database contains ESTs from multiple Citrus species. AN-2, which had the 
fewest amino acid differences with the harvEST database contig, was selected for further work. 
 
4.3 – Correction of 3’ frameshift 
 The frameshift at the 3’ end of the PGT11 insert was common to all three AN clones. In 
an effort to correct the frameshift by insertion of two or eight bases, the AN-2 insert was 
amplified from AN-2—TOPO plasmid DNA with mutagenic primers. The PCR products were 
cloned into pCR4-TOPO and transformed into E. coli. Sequencing results of DNA isolated from 
transformant colonies showed that the desired bases were not inserted. It is possible that template 
plasmid DNA, which was not destroyed or removed from the PCR mixture, was transformed 
with greater efficiency than the plasmid containing the cloned PCR product. Secondary structure 
complications of the mutagenic primers may have prevented amplification of the desired PCR 
product as well. 
 Initially, clone AN-2 had been successfully cloned into the pPICZ A vector; however it 
still contained a frameshift at its 3’ end. To correct the frameshift, a Stratagene QuikChange Kit 
was used to delete a single base between the 3’ end of the insert and the fusion tag sequence, and 
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sequencing results confirmed proper cloning and successful deletion of the single base (Figures 
9 and 10). It is notable that the mutagenesis kit uses DpnI restriction enzyme to selectively 
destroy template DNA before transformation into E.coli. The lack of DpnI digestion may 
account for the previous unsuccessful mutagenesis attempts, because both the wild-type template 
(plasmid without the desired mutation) and mutant plasmid were present in the DNA used for 
transformation of E.coli. 
 
4.4 – Expression of rPGT11 protein in P. pastoris using a PGT11-pPICZ A construct 
          corrected for frameshift 
 PGT11-pPICZ A construct corrected for the 3’ frameshift was transformed into P. 
pastoris and expression of rPGT11 was induced with methanol. Cell pellets of the induction 
cultures of four transformant colonies were collected over a 96-hour time course. An equal 
amount of protein from each induction cell pellet was analyzed by SDS-PAGE and Western blot. 
The Western blot with antibodies against the c-myc epitope showed sustained expression of 
rPGT11 in colonies 3 and 4 from 12 to 48 hours after induction, with the highest expression at 12 
hours after induction (Figures 13 and 14). Colony 3 at 12 hours was chosen for scale-up of 
expression. 
 
4.5 – Enrichment of rPGT11and flavonoid GT activity screening 
 The bulk of rPGT11 eluted from IMAC was within the fractions concentrated and used 
for activity screening; however, in future work, rPGT11 may be further enriched by using lower 
concentrations of imidazole to remove more proteins before washing with higher concentrations 
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of imidazole to elute tightly bound rPGT11 (Figure 15). The enriched rPGT11 was screened for 
activity with flavonoid substrates (Tables 26 and 27).  
 The substrates gossypetin and 4’-acetoxy-7-hydroxy-6-methoxy isoflavone showed high 
incorporation of 
14
C-glucose, which could indicate GT activity; however, the activity is not 
statistically significant because incorporation varied from low to high in duplicate reactions 
using these substrates. Such discrepancies between duplicates are often due to errors in 
extraction of products from the reaction mixture (McIntosh, personal communication). In the 
process of extraction, ethyl acetate is added to the reaction mixture and mixed by vortexing. All 
of the flavonoid content, including any glucoside products with incorporated 
14
C, is dissolved in 
the ethyl acetate layer. A portion of the upper ethyl acetate layer is removed for scintillation 
counting. Inadvertently drawing up any of the lower aqueous layer containing unused 
14
C-UDP-
glucose can greatly inflate readings. This could account for observing such wide variation 
between duplicate tests with gossypetin and 4’-acetoxy-7-hydroxy-6-methoxy isoflavone; however, 
the substrates should be re-tested before GT activity is ruled out.     
 
4.6 – Directions for future research 
 Although no significant flavonoid GT activity of rPGT11 was detected, the hypothesis 
that PGT11 is a secondary product GT is not yet disproved. Because of the instability of 
glucosyltransferases, the long purification time may have influenced the results (Owens and 
McIntosh 2011). In future work, screening should be repeated for confirmation, especially for 
those substrates for which incorporation of 
14
C varied from low to high between duplicates; such 
repetition could determine if either the low or high duplicate reading was a statistical outlier. 
Although counts for the positive control reactions using young grapefruit leaf extract were low, it 
is interesting that the positive control which contained both grapefruit extract and rPGT11 
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showed higher activity than any of the substrates tested. The rPGT11 could be using a compound 
within the extract as its substrate. If this effect is reproducible, future work could determine 
which substrates are present in the extract.  
 In addition to repetition of the work done here, future work could screen additional 
subclasses of flavonoids for activity. Flavonoids unrepresented here include chalcones, 
anthocyanidins, and dihydroflavonols. Berhow et al (1998) collected data on the phenolic content 
of Citrus species, and additional potential substrates could be chosen from aglycones for which 
glucosides exist in grapefruit. If no activity is found with any flavonoid substrates, simple 
phenolics and phenolic acids, such as those tested by Hayford (2012) and Wamucho (2012) 
could be tested. Triterpenoids such as limonoate A-ring monolactone are potential substrates as 
well (Hasegawa et al 1997). Future work could also test PGT11without a fusion tag to see if this 
has any effect on the activity. If any activity is found with PGT11 clone AN-2, then AN-1 and 
AN-3 could be tested, as well as the Citrus senensis homolog with over 80% identity and 90% 
similarity (orange1.1g012744m, www.phytozome.net). 
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Appendix A: Growth media recipes and associated stock solutions 
All chemicals and materials in this section were purchased from Fisher Scientific.  
 
1M potassium phosphate buffer (200 mL) 
4.60 g dibasic potassium phosphate 
23.63 g monobasic potassium phosphate 
Dissolve the above in ~150 mL dH2O. Adjust to pH = 6.0 with potassium or phosphoric acid; 
allow to return to room temperature before final pH adjustment. Bring volume to 200 mL with 
dH2O. Autoclave for 20 min on liquid cycle. 
 
10X GY (10% glycerol) (500 mL) 
Dissolve 50 mL of glycerol in 450 mL dH2O for a final volume of 500mL. Autoclave 20 min on 
liquid cycle. 
 
10X M (5% methanol) (500 mL) 
Mix 25 mL of methanol with 475 mL dH2O for a final volume of 500 mL. Filter sterilize.  
 
10X YNB (200 mL) 
6.80 g yeast nitrogen base (without ammonium sulfate and amino acids) 
20 g ammonium sulfate 
Heat gently but do not boil to dissolve the above in ~150 mL dH2O. Add dH2O to 200 mL. Filter 
sterilize. 
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500X B 
Dissolve 20 mg biotin in 100 mL dH2O and filter sterilize. Store at 4°C. 
 
Ampicillin (100 mg/mL) stock solution 
~100 mg ampicillin sodium powder 
~1 mL sterile dH2O 
 Into a 1.5-mL microfuge tube, weigh ~100 mg of ampicillin powder. Add 1000μL of 
dH2O per 100 mg of ampicillin. Vortex or shake the microfuge tube until the powder is dissolved 
in dH2O. (Note: Solution was not filter sterilized as it should have been.) Store 200-μL aliquots 
at -20°C.  
 
BMGY or BMMY medium for growth of Pichia pastoris (1 L) 
10 g yeast extract 
20 g peptone 
100 mL 1 M potassium phosphate buffer (pH=6.0) 
100 mL 10X YNB 
100 mL 10X G or 100mL 10X M 
2 mL 500X B 
Dissolve yeast extract and peptone in a final volume of 700 mL of dH2O. Autoclave 20 min on 
liquid cycle. Cool to RT, then (for BMGY) add phosphate buffer, 10X YNB, 10X G and 500X 
B. Mix well and store at 4°C. For BMMY, add 10X M instead of 10X G.  
 
 
80 
 
 
LBAmp (100mg/L) growth medium for Escherichia coli (400mL) 
2 g yeast extract (0.5%) 
4 g tryptone (1%) 
4 g sodium chloride (1%) 
For LB plates: 6g agar (1.5%) 
Dissolve yeast extract, tryptone, and sodium chloride in ~300 mL of dH2O. Adjust to pH=7.5 
with NaOH, then add dH2O to a final volume of 400 mL. Add agar to autoclave bottle or flask 
just before sterilizing. Autoclave 20 min on liquid cycle and cool to room temperature. Cool 
medium to ~60°C and add 400 μL of Ampicllin (100 mg/mL) stock solution. 
 
Low Salt LB growth medium for Escherichia coli (400mL): 
2 g yeast extract (0.5%) 
4 g tryptone (1%) 
2 g sodium chloride (0.5%) 
For Low Salt LB plates: 6 g agar (1.5%) 
Dissolve yeast extract, tryptone, and sodium chloride in ~300 mL of dH2O. Adjust to pH=7.5 
with NaOH, then add dH2O to a final volume of 400 mL. (For plates, add agar to autoclave bottle 
just before sterilizing.) Autoclave 20 min on liquid cycle and allow to cool to room temperature. 
For Low Salt LBZeocin (25mg/L) plates, cool plates to ~60°C before adding 100 μL of Zeocin™  
(100 mg/mL) stock solution. For Low Salt LBamp (100mg/L) plates, cool medium to ~60°C and add 
400 μL of Ampicllin (100 mg/mL) stock solution.     
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YPD growth medium for P. pastoris (400 mL): 
4 g yeast extract (1%) 
8 g peptone (2%) 
For YPD plates:  8g agar (2%) 
40 mL of 20 % dextrose (final concentration of 2%) 
Filter-sterilize or autoclave 20 % dextrose (prepared from D-α-glucose powder) solution for  
20 min on liquid cycle; cool to room temperature. Dissolve peptone and yeast extract in  
~300 mL of dH2O, then add dH2O to a final volume of 360 mL. Autoclave 20 min on liquid 
cycle and allow to cool to room temperature. Add 40 mL of filter-sterilized 20% dextrose to 
yeast extract and peptone solution, and swirl to mix. For YPDZeocin (100mg/L) plates, cool solution to 
~60°C before adding dextrose and 400μL of Zeocin™ (100mg/mL) stock solution (Appendix B).  
 
Zeocin™ (100mg/mL) stock solution 
~100mg Zeocin™ powder (Research Products International) 
~1mL sterile dH2O 
Into a 1.5-mL microfuge tube, weigh ~100mg of Zeocin™ powder. Add 1000 μL of dH2O per 
100 mg of Zeocin™. Vortex or shake the microfuge tube until the powder is dissolved in dH2O. 
(Note: Solution was not filter sterilized as it should have been.) Store 200-μL aliquots at -20°C. 
Zeocin is sensitive to light and heat. Keep in the dark when not in use (Life Technologies 2011). 
  
82 
 
Appendix B: Recipes for other buffers and solutions 
All chemicals and materials in this section were purchased from Fisher Scientific.  
 
10X Transfer buffer  
30.3 g Tris base 
144.1 g glycine 
Dissolve the above in ~900 mL of dH2O. Dilute to final volume of 1L. Prepare 1X transfer 
buffer by mixing 100 mL of 10X stock with 700 mL of dH2O and 200 mL of methanol; add 
water first to avoid precipitation of Tris and glycine.  
 
4X Separating buffer 
18.17 g Tris base 
Dissolve Tris base in 80 mL dH2O. Adjust pH to 8.8 with HCl. Allow to cool to room 
temperature before final pH adjustment. 
 
4X SDS-PAGE Sample Buffer (Wamucho 2012) 
2 mL 1M Tris base (pH = 6.9) 
2 mL 20% SDS (soium lauryl sulfate powder)  
4 mL 50% glycerol  
0.2 mg bromophenol blue 
To every 1 mL of above mixture, add 50 μL βME before use. 
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4X Stacking buffer 
12.11 g Tris base 
Dissolve Tris base in 80 mL dH2O. Adjust pH to 6.8 with HCl. Allow to cool to room 
temperature before final pH adjustment. 
 
5X TBS buffer (Sambrook et al (1989), pg. B.7) 
40 g NaCl  
1.00 g KCl  
15 g Tris base 
Dissolve the above ingredients in 800 mL dH2O, and adjust pH with HCl to 7.4. Allow solution 
to cool to room temperature before final pH adjustment. Bring up volume to 1 L with dH2O.  
 
5X Tris-glycine electrophoresis buffer (Sambrook et al 1989) (1 L) 
15.1 g Tris base 
94 g glycine 
Dissolve the above in 800 mL. Bring up volume to 950 mL with dH2O, and add 50 mL of a 10% 
SDS solution (prepared from sodium lauryl sulfate powder). 
 
50 mM sodium phosphate buffer (pH=7.5) (1 L) 
0.292 g monobasic sodium phosphate 
0.773 g dibasic sodium phosphate 
Dissolve the above in 900 mL of water. Adjust to pH = 7.5 with potassium hydroxide or 
phosphoric acid, and bring up the volume to 1000 mL with dH2O.  
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50X TAE buffer for DNA electrophoresis (1 L) (Sambrook et al. 1989) 
242 g Tris base 
57.1 mL glacial acetic acid 
100 mL 0.5M EDTA (pH=8.0)  
Dissolve all ingredients in ~700 mL of dH2O, then bring up volume to 1 L with additional dH2O. 
Store at room temperature. To make 1X working solution, mix 20 mL of 50X stock and 980 mL 
of dH2O. 
 
Alkaline Phosphatase Buffer (200 mL) 
1.17 g NaCl  
203 mg MgCl2 • 6H2O  
2.42 g Tris base  
 
Dissolve the above in 175 mL dH2O. Adjust pH to 9.5 with HCl, and bring up volume to  
200 mL. Add 60 μL each of nitro BT (0.083 g/mL in 70% N,N-dimethylformamide) and BCIP 
(0.042 mg/mL in 100% N,N-dimethylformamide) within 5 minutes of use. 
 
Breaking buffer (200 mL) 
1.38 g monobasic sodium phosphate monohydrate 
58 mg EDTA (non-salt)  
10 mL glycerol 
Dissolve the above in ~150 mL dH2O. Add 10 μL of 0.1M PMSF per mL of breaking buffer just 
before use. For purification of proteins, add βME to a final concentration of 5 mM. 
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EDTA (0.5 M), pH=8.0 (500 mL) 
73.06 g of ethylenediaminetetraacetic acid (EDTA) powder (non-salt) 
Mix EDTA and 200 mL of dH2O; EDTA will not completely dissolve. Add 6 M NaOH to the 
water and EDTA slowly, monitoring the pH. The EDTA will dissolve as the pH rises.   
 
Elution buffer (IMAC) (1L) 
0.292 g monobasic sodium phosphate 
0.773 g dibasic sodium phosphate 
17.53 g sodium chloride  
10.21 g imidizole 
Dissolve the above in 900 mL of water. Adjust to pH = 7.5 with potassium hydroxide or 
phosphoric acid, and bring up the volume to 1000 mL with dH2O. 
 
Equilibration/wash buffer (pH=7.5) (1 L) 
0.292 g monobasic sodium phosphate 
0.773 g dibasic sodium phosphate 
17.53 g sodium chloride  
Dissolve the above in 900 mL of water. Adjust to pH = 7.5 with potassium hydroxide or 
phosphoric acid, and bring up the volume to 1000 mL with dH2O. 
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MES buffer (pH=5.0) 
3.90 g 2-(N-morpholino)ethanesulfonic acid (MES) 
Dissolve above in 900 mL dH2O, and adjust to pH=5.0. Add dH2O to 1000 mL. 
